| Pacific Fertility Center Los Angeles (PFCLA) | 74.5 | 3 | 3 |
| Prelude Fertility | 67.3 | 3 | 2 |
| EurekAlert! | 60.0 | 7 | 0 |
| Pacific Fertility Center | 57.2 | 3 | 1 |
| Fertility Center of San Antonio | 48.9 | 2 | 1 |
| Colorado Center for Reproductive Medicine | 48.9 | 2 | 1 |
| Shady Grove Fertility Center | 48.9 | 2 | 1 |
| New Hope Fertility Center | 48.9 | 2 | 1 |
| Pacific Centre for Reproductive Medicine | 48.9 | 2 | 1 |
| Mayo Clinic | 46.4 | 4 | 0 |
| Human Rights Campaign | 46.4 | 4 | 0 |
| CNN.com | 46.4 | 4 | 0 |
| assisted reproductive technology | 40.0 | 0 | 4 |
| Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? | 40.0 | 0 | 4 |
| Uncommon but devastating event: total fertilisation failure following intracytoplasmic sperm injection | 40.0 | 0 | 4 |
| The question of sperm DNA fragmentation testing in the male infertility work-up: a response to Professor Lewis' commentary | 40.0 | 0 | 4 |
| National Institute for Occupational Safety and Health | 40.0 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 40.0 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 40.0 | 3 | 0 |
| Office of Readiness and Response | 40.0 | 3 | 0 |
| American Society for Reproductive Medicine | 37.2 | 1 | 1 |
| Reproductive Medicine Associates of New York | 37.2 | 1 | 1 |
| Reproductive Medicine Associates of New Jersey | 37.2 | 1 | 1 |
| fertility clinic | 34.5 | 0 | 3 |
| Fertility and Sterility | 34.5 | 0 | 3 |
| What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation? | 34.5 | 0 | 3 |
| Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic | 34.5 | 0 | 3 |
| Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination | 34.5 | 0 | 3 |
| Fertility clinic, egg donation agency, and sperm bank policies | 34.5 | 0 | 3 |
| Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study | 34.5 | 0 | 3 |
| Conversion from assisted reproductive technology to intrauterine insemination in low responders: is it advantageous? | 34.5 | 0 | 3 |
| The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility | 34.5 | 0 | 3 |
| What is the most relevant standard of success in assisted reproduction?: challenges in measuring and reporting success rates for assisted reproductive technology treatments: what is optimal? | 34.5 | 0 | 3 |
| Predictive value of sperm motility characteristics assessed by computer-assisted sperm analysis in intrauterine insemination with superovulation in couples with unexplained infertility | 34.5 | 0 | 3 |
| ICSI treatment of severe male infertility can achieve prospective embryo quality compared with IVF of fertile donor sperm on sibling oocytes | 34.5 | 0 | 3 |
| Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism | 34.5 | 0 | 3 |
| Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injection | 34.5 | 0 | 3 |
| A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey | 34.5 | 0 | 3 |
| Embryo transfer in days 2 to 4 following intracytoplasmic sperm injection: a prospective cohort study | 34.5 | 0 | 3 |
| Genetic considerations related to intracytoplasmic sperm injection (ICSI). | 34.5 | 0 | 3 |
| The Effects of Total Motile Sperm Count on Spontaneous Pregnancy Rate and Pregnancy After IUI Treatment in Couples with Male Factor and Unexplained Infertility | 34.5 | 0 | 3 |
| Comparing blastocyst quality and live birth rates of intravaginal culture using INVOcell™ to traditional in vitro incubation in a randomized open-label prospective controlled trial | 34.5 | 0 | 3 |
| Preimplantation genetic testing: a Practice Committee opinion | 34.5 | 0 | 3 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 34.5 | 0 | 3 |
| Blastocyst Transfer Ameliorates Live Birth Rate Compared with Cleavage-Stage Embryos Transfer in FreshIn VitroFertilization or Intracytoplasmic Sperm Injection Cycles: Reviews and Meta-Analysis | 34.5 | 0 | 3 |
| Elective single-embryo transfer | 34.5 | 0 | 3 |
| Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion | 34.5 | 0 | 3 |
| Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion | 34.5 | 0 | 3 |
| Effect of Prednisolone Administration on Patients with Unexplained Recurrent Miscarriage and in Routine Intracytoplasmic Sperm Injection: A Meta‐Analysis | 34.5 | 0 | 3 |
| Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination | 34.5 | 0 | 3 |
| Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 34.5 | 0 | 3 |
| Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility. | 34.5 | 0 | 3 |
| Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012 | 34.5 | 0 | 3 |
| Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials | 34.5 | 0 | 3 |
| Mature oocyte cryopreservation: a guideline | 34.5 | 0 | 3 |
| Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial | 34.5 | 0 | 3 |
| Retracted: Cervical mucus removal prior to intrauterine insemination: a randomized trial | 34.5 | 0 | 3 |
| Comparison of pregnancy rates in pre-treatment male infertility and low total motile sperm count at insemination | 34.5 | 0 | 3 |
| There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy | 34.5 | 0 | 3 |
| Effect of endometrial thickness on pregnancy outcome after intracytoplasmic sperm injection | 34.5 | 0 | 3 |
| Comparison of estradiol and progesterone priming/antagonist/letrozole and microdose flare-up protocols for poor responders undergoing intracytoplasmic sperm injection | 34.5 | 0 | 3 |
| Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles | 34.5 | 0 | 3 |
| What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility clinics? | 34.5 | 0 | 3 |
| Recommendations for gamete and embryo donation: a committee opinion | 34.5 | 0 | 3 |
| 2008 Guidelines for gamete and embryo donation: a Practice Committee report | 34.5 | 0 | 3 |
| Essential elements of informed consent for elective oocyte cryopreservation: a Practice Committee opinion | 34.5 | 0 | 3 |
| The role of in vitro fertilization and intracytoplasmic sperm injection in couples with unexplained infertility after failed intrauterine insemination | 34.5 | 0 | 3 |
| Male Infertility Diagnosis and Treatment in the Era of In Vitro Fertilization and Intracytoplasmic Sperm Injection | 34.5 | 0 | 3 |
| 1995 assisted reproductive technology success rates: national summary and fertility clinic report. | 34.5 | 0 | 3 |
| 2006 Guidelines for Gamete and Embryo Donation | 34.5 | 0 | 3 |
| Retrospective Study to Compare Frozen-Thawed Embryo Transfer with Fresh Embryo Transfer on Pregnancy Outcome Following Intracytoplasmic Sperm Injection for Male Infertility. | 34.5 | 0 | 3 |
| LANDA Embryo Freezing Technique. | 34.5 | 0 | 3 |
| Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics | 34.5 | 0 | 3 |
| Egg Freezing Pilot Study | 34.5 | 0 | 3 |
| Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility | 34.5 | 0 | 3 |
| Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates | 34.5 | 0 | 3 |
| 0.2 ml vs. 0.5 Inseminated Volume in Donor Intrauterine Insemination Cycles: A Prospective RCT | 34.5 | 0 | 3 |
| Randomized comparison of ovulation induction with and without intrauterine insemination in the treatment of unexplained infertility | 34.5 | 0 | 3 |
| Success rates following intracytoplasmic sperm injection are improved by using ZIFT vs IVF for embryo transfer | 34.5 | 0 | 3 |
| The results of in vitro fertilization-embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination | 34.5 | 0 | 3 |
| Comparable clinical outcomes of tubal embryo transfer for oligoastheno-teratozoospermia treated with intracytoplasmic sperm injection and for female infertility treated with in vitro fertilization | 34.5 | 0 | 3 |
| Ovarian tissue and oocyte cryopreservation | 34.5 | 0 | 3 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 34.5 | 0 | 3 |
| Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 34.5 | 0 | 3 |
| The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation | 34.5 | 0 | 3 |
| In vitro fertilization laboratory. Clinical features of assisted reproduction techniques. Male infertility treatment in a reproduction medicine centre | 34.5 | 0 | 3 |
| Preimplantation genetic testing: a Practice Committee opinion | 34.5 | 0 | 3 |
| Genetic considerations related to intracytoplasmic sperm injection (ICSI) | 34.5 | 0 | 3 |
| Ovarian tissue and oocyte cryopreservation | 34.5 | 0 | 3 |
| Outcomes of in vitro fertilization-embryo transfer and intracytoplasmic sperm injection for non-male infertility patients with a low number of oocytes retrieved | 34.5 | 0 | 3 |
| Processing of semen by density gradient centrifugation selects spermatozoa with longer telomeres for assisted reproduction techniques | 34.5 | 0 | 3 |
| The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion | 34.5 | 0 | 3 |
| Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion | 34.5 | 0 | 3 |
| Reporting assisted reproductive technology success rates on Australian and New Zealand fertility clinic websites | 34.5 | 0 | 3 |
| Assisted Reproductive Technology and the Reproductive Endocrinology and Infertility Specialist in the U.S. Military | 34.5 | 0 | 3 |
| Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion | 34.5 | 0 | 3 |
| Androgenicity and fertility treatment in women with unexplained infertility | 34.5 | 0 | 3 |
| Reproductive endocrinologists are the gatekeepers for male infertility care in North America: results of a North American survey on the referral patterns and characteristics of men presenting to male infertility specialists for infertility investiga | 34.5 | 0 | 3 |
| Delayed frozen embryo transfer failed to improve live birth rate and neonatal outcomes in patients requiring whole embryo freezing | 34.5 | 0 | 3 |
| Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population | 34.5 | 0 | 3 |
| Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial | 34.5 | 0 | 3 |
| Intracytoplasmic sperm injection (ICSI) for non-male factor indications: a committee opinion | 34.5 | 0 | 3 |
| Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome System study | 34.5 | 0 | 3 |
| Short-term weight change and live birth among women with unexplained infertility and polycystic ovary syndrome undergoing ovulation induction | 34.5 | 0 | 3 |
| Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database | 34.5 | 0 | 3 |
| Association between the number of oocytes retrieved and cumulative live birth rate in IVF treatment: menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial outcomes | 34.5 | 0 | 3 |
| GYN-FIV a.s. | 34.5 | 0 | 3 |
| Massachusetts General Hospital | 31.7 | 2 | 0 |
| Newsweek | 31.7 | 2 | 0 |
| Ferring Pharmaceuticals | 31.7 | 2 | 0 |
| U.S. News & World Report | 31.7 | 2 | 0 |
| The Star-Ledger | 31.7 | 2 | 0 |
| Epi Info | 31.7 | 2 | 0 |
| Sara Sidner | 31.7 | 2 | 0 |
| Cleveland Clinic | 31.7 | 2 | 0 |
| Crossfire | 31.7 | 2 | 0 |
| Duke University Health System | 31.7 | 2 | 0 |
| Fareed Zakaria GPS | 31.7 | 2 | 0 |
| Military Health System | 31.7 | 2 | 0 |
| Preventing Chronic Disease | 31.7 | 2 | 0 |
| Reliable Sources | 31.7 | 2 | 0 |
| Riverside University Health System - Medical Center | 31.7 | 2 | 0 |
| University of Pittsburgh Medical Center | 31.7 | 2 | 0 |
| National Health Service | 31.7 | 2 | 0 |
| NJ.com | 31.7 | 2 | 0 |
| National Survey of Family Growth | 31.7 | 2 | 0 |
| National Vital Statistics System | 31.7 | 2 | 0 |
| NIOSH Power Tools Database | 31.7 | 2 | 0 |
| UCLA Health System | 31.7 | 2 | 0 |
| Luton and Dunstable University Hospital NHS Foundation Trust | 31.7 | 2 | 0 |
| The Sixties | 31.7 | 2 | 0 |
| CNNGo | 31.7 | 2 | 0 |
| United Shades of America | 31.7 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 31.7 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 31.7 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 31.7 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 31.7 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 31.7 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 31.7 | 2 | 0 |
| NCHS data brief | 31.7 | 2 | 0 |
| MMWR supplements | 31.7 | 2 | 0 |
| U.S. News & World Report Best Colleges Ranking | 31.7 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 31.7 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 31.7 | 2 | 0 |
| Boscombe Community Hospital | 31.7 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 31.7 | 2 | 0 |
| UPMC Health System | 31.7 | 2 | 0 |
| Johns Hopkins Medicine | 31.7 | 2 | 0 |
| azoospermia | 27.3 | 0 | 2 |
| egg donation | 27.3 | 0 | 2 |
| Vitrification (ovocytes) | 27.3 | 0 | 2 |
| Journal of Assisted Reproduction and Genetics | 27.3 | 0 | 2 |
| Reproductive Medicine and Biology | 27.3 | 0 | 2 |
| Naprotechnology | 27.3 | 0 | 2 |
| Semen analysis and fertility assessment in rabbits: statistical power and design considerations for toxicology studies | 27.3 | 0 | 2 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 27.3 | 0 | 2 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 27.3 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 27.3 | 0 | 2 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 27.3 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 27.3 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproductive technology | 27.3 | 0 | 2 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 27.3 | 0 | 2 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial | 27.3 | 0 | 2 |
| Monochorionic-triamniotic triplet pregnancy after intracytoplasmic sperm injection, assisted hatching, and two-embryo transfer: first reported case following IVF | 27.3 | 0 | 2 |
| Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility | 27.3 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 27.3 | 0 | 2 |
| A Review of The Society for Assisted Reproductive Technology Embryo Grading System and Proposed Modification | 27.3 | 0 | 2 |
| Surgery for endometriosis-associated infertility: do we exaggerate the magnitude of effect? | 27.3 | 0 | 2 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 27.3 | 0 | 2 |
| The evaluation of pre and post processing semen analysis parameters at the time of intrauterine insemination in couples diagnosed with male factor infertility and pregnancy rates based on stimulation agent. A retrospective cohort study | 27.3 | 0 | 2 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 27.3 | 0 | 2 |
| Is a male infertility clinic of any use? | 27.3 | 0 | 2 |
| Maternal whole grain intake and outcomes of in vitro fertilization | 27.3 | 0 | 2 |
| Urinary phthalate metabolites and ovarian reserve among women seeking infertility care | 27.3 | 0 | 2 |
| Is a Male Infertility Clinic of Any Use? | 27.3 | 0 | 2 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. | 27.3 | 0 | 2 |
| Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome. | 27.3 | 0 | 2 |
| Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility | 27.3 | 0 | 2 |
| Predictors of participant retention in infertility treatment trials | 27.3 | 0 | 2 |
| Altering hirsutism through ovulation induction in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Frequency of the male infertility evaluation: data from the national survey of family growth | 27.3 | 0 | 2 |
| Risk of major congenital anomalies after assisted hatching: analysis of three-year data from the national assisted reproduction registry in Japan | 27.3 | 0 | 2 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion | 27.3 | 0 | 2 |
| Pregnancy outcomes after assisted reproductive technology | 27.3 | 0 | 2 |
| Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique | 27.3 | 0 | 2 |
| Advances in microsurgery and assisted reproduction for management of male infertility | 27.3 | 0 | 2 |
| Decline in sperm count and motility in young adult men from 2003 to 2013: observations from a U.S. sperm bank | 27.3 | 0 | 2 |
| Artificial insemination and use of a sperm bank at the fertility clinic of the C.H.U.L. (Centre hospitalier de l'université Larval) | 27.3 | 0 | 2 |
| Increasing and decreasing factors of hope in infertile women with failure in infertility treatment: A phenomenology study | 27.3 | 0 | 2 |
| Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial | 27.3 | 0 | 2 |
| The status of assisted reproductive technology in Korea in 2012 | 27.3 | 0 | 2 |
| Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates | 27.3 | 0 | 2 |
| Analysis of oocyte cryopreservation in assisted reproduction: the Italian National Register data from 2005 to 2007 | 27.3 | 0 | 2 |
| The impact of letrozole versus clomiphene citrate on uterine blood flow in patients with unexplained infertility | 27.3 | 0 | 2 |
| Ethical Issues Currently Being Discussed in Relation to Reproductive Medicine and the Laws Governing Reproductive Medicine | 27.3 | 0 | 2 |
| National collection of embryo morphology data into Society for Assisted Reproductive Technology Clinic Outcomes Reporting System: associations among day 3 cell number, fragmentation and blastomere asymmetry, and live birth rate | 27.3 | 0 | 2 |
| Women's perceptions and experiences of the challenges in the process of male infertility treatment: A qualitative study. | 27.3 | 0 | 2 |
| The incidence of monozygotic twinning in assisted reproductive technology: Analysis based on results from the 2010 Japanese ART national registry | 27.3 | 0 | 2 |
| A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T) | 27.3 | 0 | 2 |
| Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers | 27.3 | 0 | 2 |
| The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction | 27.3 | 0 | 2 |
| Contemporary approach to the male infertility evaluation | 27.3 | 0 | 2 |
| The effect of patient and semen characteristics on live birth rates following intrauterine insemination: a retrospective study | 27.3 | 0 | 2 |
| Effectiveness of in vitro fertilization with intracytoplasmic sperm injection for severe male infertility. | 27.3 | 0 | 2 |
| Genetically determined male infertility and assisted reproduction techniques | 27.3 | 0 | 2 |
| How the FMR1 gene became relevant to female fertility and reproductive medicine | 27.3 | 0 | 2 |
| Single-donor and double-donor sperm intrauterine insemination cycles: does double intrauterine insemination increase clinical pregnancy rates? | 27.3 | 0 | 2 |
| Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. | 27.3 | 0 | 2 |
| The gradient technique improves success rates in intrauterine insemination cycles of unexplained subfertile couples when compared to swim up technique; a prospective randomized study | 27.3 | 0 | 2 |
| The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer | 27.3 | 0 | 2 |
| Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes | 27.3 | 0 | 2 |
| Predictors of not pursuing infertility treatment after an infertility diagnosis: examination of a prospective U.S. cohort | 27.3 | 0 | 2 |
| Male infertility and intracytoplasmic sperm injection (ICSI). | 27.3 | 0 | 2 |
| The future of male infertility management and assisted reproduction technology | 27.3 | 0 | 2 |
| Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents | 27.3 | 0 | 2 |
| An overview of male infertility in the era of intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011. | 27.3 | 0 | 2 |
| Compounded bioidentical menopausal hormone therapy | 27.3 | 0 | 2 |
| Intracytoplasmic sperm injection facilitates fertilization even in the most severe forms of male infertility: pregnancy outcome correlates with maternal age and number of eggs available. | 27.3 | 0 | 2 |
| Empirical medical therapy in idiopathic male infertility: Promise or panacea? | 27.3 | 0 | 2 |
| Is tubal embryo transfer of any value? A meta-analysis and comparison with the Society for Assisted Reproductive Technology database | 27.3 | 0 | 2 |
| Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study. | 27.3 | 0 | 2 |
| Opinion : how should we define success in assisted reproduction? is live birth rate the gold standard measurement? | 27.3 | 0 | 2 |
| Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Cumulative live birth rate and assisted reproduction: impact of female age and transfer day | 27.3 | 0 | 2 |
| Mitochondrial replacement therapy in reproductive medicine | 27.3 | 0 | 2 |
| Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility | 27.3 | 0 | 2 |
| Age, body mass index, and number of previous trials: are they prognosticators of intra-uterine-insemination for infertility treatment? | 27.3 | 0 | 2 |
| Births of normal daughters after MicroSort sperm separation and intrauterine insemination, in-vitro fertilization, or intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment | 27.3 | 0 | 2 |
| Infertility evaluation via laparoscopy and hysteroscopy after conservative treatment for tubal pregnancy | 27.3 | 0 | 2 |
| The presence of multiple gestational sacs confers a higher live birth rate in women with infertility who achieve a positive pregnancy test after fresh and frozen embryo transfer: a retrospective local cohort | 27.3 | 0 | 2 |
| Estradiol progesterone ratio on ovulation induction day: a determinant of successful pregnancy outcome after intra cytoplasmic sperm injection | 27.3 | 0 | 2 |
| Intracytoplasmic Sperm Injection (ICSI) in Extreme Cases of Male Infertility | 27.3 | 0 | 2 |
| Cumulative live birth rate after two single frozen embryo transfers (eSFET) versus a double frozen embryo transfer (DFET) with cleavage stage embryos: a retrospective cohort study. | 27.3 | 0 | 2 |
| Oocyte Cryopreservation for Fertility Preservation in Postpubertal Female Children at Risk for Premature Ovarian Failure Due to Accelerated Follicle Loss in Turner Syndrome or Cancer Treatments | 27.3 | 0 | 2 |
| Deep intrauterine insemination and embryo transfer in pigs. | 27.3 | 0 | 2 |
| Effect of ethnicity on live birth rates after in vitro fertilisation or intracytoplasmic sperm injection treatment. | 27.3 | 0 | 2 |
| Effect of cell phone usage on semen analysis in men attending infertility clinic: an observational study | 27.3 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion | 27.3 | 0 | 2 |
| Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway | 27.3 | 0 | 2 |
| Effect of Sperm Count on Success of Intrauterine Insemination in Couples Diagnosed with Male Factor Infertility | 27.3 | 0 | 2 |
| Association of assisted reproductive technology (ART) treatment and parental infertility diagnosis with autism in ART-conceived children | 27.3 | 0 | 2 |
| Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterin | 27.3 | 0 | 2 |
| Semen Analysis: A Review of Samples from 225 Men Seen at an Infertility Clinic | 27.3 | 0 | 2 |
| A healthy delivery of twins by assisted reproduction followed by preimplantation genetic screening in a woman with X-linked dominant incontinentia pigmenti | 27.3 | 0 | 2 |
| Use of complementary and alternative medicines associated with a 30% lower ongoing pregnancy/live birth rate during 12 months of fertility treatment | 27.3 | 0 | 2 |
| Gonadotrophins: The future | 27.3 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 27.3 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 27.3 | 0 | 2 |
| What the urologist should know about the female infertility evaluation | 27.3 | 0 | 2 |
| In vitro fertilization/intracytoplasmic sperm injection for male infertility | 27.3 | 0 | 2 |
| Can hyaluronan binding assay predict the outcome of intrauterine insemination in couples with unexplained or mild male factor infertility? | 27.3 | 0 | 2 |
| Male infertility and copy number variants (CNVs) in the dog: a two-pronged approach using Computer Assisted Sperm Analysis (CASA) and Fluorescent In Situ Hybridization (FISH). | 27.3 | 0 | 2 |
| Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial | 27.3 | 0 | 2 |
| Outcomes with intracytoplasmic sperm injection of cryopreserved sperm from men with spinal cord injury | 27.3 | 0 | 2 |
| Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients | 27.3 | 0 | 2 |
| The comparison between Intrauterine Insemination and Fallopian Tube Sperm Perfusion Using FAST®System in Patients with Unexplained Infertility | 27.3 | 0 | 2 |
| Surgical treatment of male infertility in the era of intracytoplasmic sperm injection – new insights | 27.3 | 0 | 2 |
| Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone | 27.3 | 0 | 2 |
| The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? | 27.3 | 0 | 2 |
| Low dose hormone therapy in reproductive endocrinology in China | 27.3 | 0 | 2 |
| Application of a validated prediction model for in vitro fertilization: comparison of live birth rates and multiple birth rates with 1 embryo transferred over 2 cycles vs 2 embryos in 1 cycle | 27.3 | 0 | 2 |
| Cost and safety of assisted reproductive technologies for human immunodeficiency virus-1 discordant couples | 27.3 | 0 | 2 |
| A legal-ethical analysis of reproductive endocrinologists' right to refuse ovulation induction to patients with diminished ovarian reserve | 27.3 | 0 | 2 |
| Live birth rates using conventional in vitro fertilization compared to intracytoplasmic sperm injection in Bologna poor responders with a single oocyte retrieved. | 27.3 | 0 | 2 |
| Pregnancy-related complications and adverse pregnancy outcomes in multiple pregnancies resulting from assisted reproductive technology: a meta-analysis of cohort studies | 27.3 | 0 | 2 |
| Intrauterine insemination: a UK survey on the adherence to NICE clinical guidelines by fertility clinics | 27.3 | 0 | 2 |
| Clinical analysis of spontaneous pregnancy reduction in the patients with multiple pregnancies undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 27.3 | 0 | 2 |
| Deficiencies in reporting results of lesbians and gays after donor intrauterine insemination and assisted reproductive technology treatments: a review of the first emerging studies | 27.3 | 0 | 2 |
| Optimal timing for elective egg freezing | 27.3 | 0 | 2 |
| Does obesity have detrimental effects on IVF treatment outcomes? | 27.3 | 0 | 2 |
| Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination | 27.3 | 0 | 2 |
| Human iPS Cell-Derived Germ Cells: Current Status and Clinical Potential | 27.3 | 0 | 2 |
| Patients with polycystic ovary syndrome have successful embryo arrest | 27.3 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality | 27.3 | 0 | 2 |
| Management of the first in vitro fertilization cycle for unexplained infertility: a cost-effectiveness analysis of split in vitro fertilization-intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Report on evaluation of the azoospermic male | 27.3 | 0 | 2 |
| Report on management of obstructive azoospermia | 27.3 | 0 | 2 |
| Report on varicocele and infertility | 27.3 | 0 | 2 |
| Effectiveness and treatment for unexplained infertility | 27.3 | 0 | 2 |
| Assisted reproductive technology and risk of adverse obstetric outcomes in dichorionic twin pregnancies: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Ovarian tissue and oocyte cryopreservation | 27.3 | 0 | 2 |
| Frozen blastocyst embryo transfer using a supplemented natural cycle protocol has a similar live birth rate compared to a programmed cycle protocol | 27.3 | 0 | 2 |
| Clinical application of sperm-oocyte interaction tests in in vitro fertilization--embryo transfer and intracytoplasmic sperm injection programs | 27.3 | 0 | 2 |
| Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles | 27.3 | 0 | 2 |
| The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal? | 27.3 | 0 | 2 |
| Effect of Embryo Banking on U.S. National Assisted Reproductive Technology Live Birth Rates | 27.3 | 0 | 2 |
| Gonadotrophin ovarian stimulation and intrauterine insemination for unexplained infertility | 27.3 | 0 | 2 |
| Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Life table (survival) analysis to generate cumulative pregnancy rates in assisted reproduction: are we overestimating our success rates? | 27.3 | 0 | 2 |
| Undergoing varicocele repair before assisted reproduction improves pregnancy rate and live birth rate in azoospermic and oligospermic men with a varicocele: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Effect of endometrial biopsy on intrauterine insemination outcome in controlled ovarian stimulation cycle | 27.3 | 0 | 2 |
| Sperm chromatin structure assay results in Nigerian men with unexplained infertility | 27.3 | 0 | 2 |
| Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention | 27.3 | 0 | 2 |
| Three pro-nuclei (3PN) incidence factors and clinical outcomes: a retrospective study from the fresh embryo transfer of in vitro fertilization with donor sperm (IVF-D) | 27.3 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Comparison of different starting gonadotropin doses (50, 75 and 100 IU daily) for ovulation induction combined with intrauterine insemination | 27.3 | 0 | 2 |
| The current status of sperm donation in assisted reproduction technology: ethical and legal considerations | 27.3 | 0 | 2 |
| An open multicenter study to compare the efficacy of intraperitoneal insemination and intrauterine insemination following multiple follicular development as treatment for unexplained infertility | 27.3 | 0 | 2 |
| Comparison of the role of cervical and intrauterine insemination techniques on the incidence of multiple pregnancy after artificial insemination with donor sperm | 27.3 | 0 | 2 |
| Sperm chromatin stability and its relationship with fertilization rate after intracytoplasmic sperm injection (ICSI) in an assisted reproduction program | 27.3 | 0 | 2 |
| A prospective randomized trial of conventional in vitro fertilization versus intracytoplasmic sperm injection in unexplained infertility | 27.3 | 0 | 2 |
| In vitro fertilization and intracytoplasmic sperm injection for couples with unexplained infertility after failed direct intraperitoneal insemination | 27.3 | 0 | 2 |
| Two different timings of intrauterine insemination for non-male infertility | 27.3 | 0 | 2 |
| Is intracytoplasmic sperm injection necessary for couples undergoing in vitro fertilization-embryo transfer with normal semen analyses but failing hamster egg penetration assays? | 27.3 | 0 | 2 |
| Intracytoplasmic sperm injection and conventional in vitro fertilization are complementary techniques in management of unexplained infertility. | 27.3 | 0 | 2 |
| Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis | 27.3 | 0 | 2 |
| The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program | 27.3 | 0 | 2 |
| Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost- and clinical effectiveness | 27.3 | 0 | 2 |
| Micromanipulation in assisted reproductive technology: intracytoplasmic sperm injection, assisted hatching, and preimplantation genetic diagnosis | 27.3 | 0 | 2 |
| Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons | 27.3 | 0 | 2 |
| Identification of small segmental translocations in patients with repeated implantation failure and recurrent miscarriage using next generation sequencing after in vitro fertilization/intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination | 27.3 | 0 | 2 |
| Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction | 27.3 | 0 | 2 |
| Oncofertility: a grand collaboration between reproductive medicine and oncology | 27.3 | 0 | 2 |
| Intrauterine insemination catheters for assisted reproduction: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Anti-Müllerian hormone levels as a predictor of clinical pregnancy inin vitrofertilization/intracytoplasmic sperm injection-embryo transfer cycles in patients over 40 years of age | 27.3 | 0 | 2 |
| Intracytoplasmic sperm injection--an assisted reproduction technique that should make us cautious about imprinting deregulation | 27.3 | 0 | 2 |
| Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles | 27.3 | 0 | 2 |
| Comparison of Ovarian volume and Antral follicle count with Endocrine tests for prediction of responsiveness in ovulation induction protocols | 27.3 | 0 | 2 |
| Age-Related Normogram for Ovarian Antral Follicle Count in Women with Polycystic Ovary Syndrome and Comparison with Age Matched Controls Using Magnetic Resonance Imaging | 27.3 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 27.3 | 0 | 2 |
| Round spermatid nucleus injection (ROSNI). | 27.3 | 0 | 2 |
| Report on optimal evaluation of the infertile male | 27.3 | 0 | 2 |
| A reassessment of comparative pregnancy and implantation rates following embryo transfer in recipients vs their infertile donors also trying to conceive in the background of performing salpingectomy for hydrosalpinx. | 27.3 | 0 | 2 |
| Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. | 27.3 | 0 | 2 |
| Effect of polyvinylpyrrolidone on sperm function and early embryonic development following intracytoplasmic sperm injection in human assisted reproduction | 27.3 | 0 | 2 |
| Use of acupuncture in female infertility and a summary of recent acupuncture studies related to embryo transfer. | 27.3 | 0 | 2 |
| Semen analysis is the cornerstone of investigation for male infertility | 27.3 | 0 | 2 |
| Computer-assisted semen analysis systems: comparison with routine evaluation and prognostic value in male fertility and assisted reproduction | 27.3 | 0 | 2 |
| Current status of assisted reproductive technology in Korea, 2011 | 27.3 | 0 | 2 |
| A Comparison of Success Rates of Embryo Transfer on Weekdays and Weekends | 27.3 | 0 | 2 |
| Intrafollicular ovarian pregnancy after ovulation induction/intrauterine insemination: pathophysiological aspects and diagnostic problems. | 27.3 | 0 | 2 |
| Some Interrelationships Between Plasma Levels of LH, FSH, Oestradiol 17β, Androgens and Semen Analysis Data in Male Infertility Patients | 27.3 | 0 | 2 |
| Recent data on the treatment of unexplained infertility with clomiphene citrate, intrauterine insemination, and in vitro fertilization | 27.3 | 0 | 2 |
| Insurance coverage for male infertility care in the United States | 27.3 | 0 | 2 |
| Outcomes of intracytoplasmic sperm injection using the zona pellucida-bound sperm or manually selected sperm | 27.3 | 0 | 2 |
| Use of letrozole in assisted reproduction: a systematic review and meta-analysis. | 27.3 | 0 | 2 |
| A review of mathematical models used to determine sperm donor limits for infertility treatment | 27.3 | 0 | 2 |
| Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles | 27.3 | 0 | 2 |
| Predictive value of hormonal parameters for live birth in women with unexplained infertility and male infertility | 27.3 | 0 | 2 |
| Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction | 27.3 | 0 | 2 |
| Post-thaw Embryo Transfer Cycles as the Future Hope for Boosting IVF Success Rates | 27.3 | 0 | 2 |
| Standardized Infertility Treatments not only Ensure Maternal-Fetal Health but also Provide Higher Success Rates | 27.3 | 0 | 2 |
| Introduction of sensitive and specific biomarkers can improve infertility treatment success rates | 27.3 | 0 | 2 |
| Using the alkaline comet assay in prognostic tests for male infertility and assisted reproductive technology outcomes | 27.3 | 0 | 2 |
| Influences on endometrial development during intrauterine insemination: clinical experience of 2,929 patients with unexplained infertility | 27.3 | 0 | 2 |
| Approach to Male Infertility and Induction of Spermatogenesis | 27.3 | 0 | 2 |
| Which is the best intrauterine insemination timing choice following exogenous hCG administration during ovulation induction by using clomiphene citrate treatment? A retrospective study | 27.3 | 0 | 2 |
| Single-embryo transfer reduces clinical pregnancy rates and live births in fresh IVF and Intracytoplasmic Sperm Injection (ICSI) cycles: a meta-analysis | 27.3 | 0 | 2 |
| An evaluation of embryo, zygote and oocyte cryopreservation in assisted reproductive technology | 27.3 | 0 | 2 |
| Pregnancy Predictors after Intrauterine Insemination in Cases of Unexplained Infertility: A Prospective Study. | 27.3 | 0 | 2 |
| Assisted reproduction and fertility preservation techniques in cancer patients | 27.3 | 0 | 2 |
| Optimizing natural fertility | 27.3 | 0 | 2 |
| Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles | 27.3 | 0 | 2 |
| Assisted reproductive technology use, embryo transfer practices, and birth outcomes after infertility insurance mandates: New Jersey and Connecticut | 27.3 | 0 | 2 |
| A prospective randomized study to evaluate the effect of hyaluronic acid sperm selection on the intracytoplasmic sperm injection outcome of patients with unexplained infertility having normal semen parameters | 27.3 | 0 | 2 |
| Sperm Chromatin Dispersion Test before Sperm Preparation Is Predictive of Clinical Pregnancy in Cases of Unexplained Infertility Treated with Intrauterine Insemination and Induction with Clomiphene Citrate | 27.3 | 0 | 2 |
| Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches | 27.3 | 0 | 2 |
| A strict infertility diagnosis has poor agreement with the clinical diagnosis entered into the Society for Assisted Reproductive Technology registry | 27.3 | 0 | 2 |
| Successful pregnancy and delivery of two sets of monozygotic twins after intracytoplasmic sperm injection and embryo transfer: case report and literature review | 27.3 | 0 | 2 |
| A comparative study on the results of agonist and antagonist protocols based on serum AMH levels in patients undergoing intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Validation of infertility treatment and assisted reproductive technology use on the birth certificate in eight states | 27.3 | 0 | 2 |
| Direct-to-consumer advertising of success rates for medically assisted reproduction: a review of national clinic websites | 27.3 | 0 | 2 |
| A rare and interesting case of heterotopic cervical pregnancy after intracytoplasmic sperm injection and embryo transfer | 27.3 | 0 | 2 |
| Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms | 27.3 | 0 | 2 |
| American Society for Reproductive Medicine: defining embryo donation | 27.3 | 0 | 2 |
| Semen preparation techniques in intrauterine insemination: A comparison of non-temperature and temperature controlled centrifugation in cases of unexplained infertility | 27.3 | 0 | 2 |
| What should be the first-line treatment for unexplained infertility in women over 40 years of age - ovulation induction and IUI, or IVF? | 27.3 | 0 | 2 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 27.3 | 0 | 2 |
| Effect of Pertubation on Pregnancy Rates before Intrauterine Insemination Treatment in Patients with Unexplained Infertility | 27.3 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 27.3 | 0 | 2 |
| The Walking Egg Project: Universal access to infertility care - from dream to reality | 27.3 | 0 | 2 |
| Decisions on embryo disposition in cross-border reproductive care: differences between Belgian and Dutch patients at a Belgian fertility center | 27.3 | 0 | 2 |
| Global access to infertility care in developing countries: a case of human rights, equity and social justice | 27.3 | 0 | 2 |
| Barriers to access to infertility care and assisted reproductive technology within the public health sector in Brazil | 27.3 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 27.3 | 0 | 2 |
| Fertility preservation and infertility treatment in breast cancer patients | 27.3 | 0 | 2 |
| The role of intrauterine insemination in male infertility | 27.3 | 0 | 2 |
| Sperm retrieval for azoospermia and intracytoplasmic sperm injection success rates – A personal overview | 27.3 | 0 | 2 |
| The promise of in vitro maturation in assisted reproduction and fertility preservation. | 27.3 | 0 | 2 |
| Oocyte cryopreservation as a fertility preservation measure for cancer patients | 27.3 | 0 | 2 |
| Clinical management of male infertility in assisted reproduction: ICSI and beyond | 27.3 | 0 | 2 |
| Prevalence of genital chlamydia and mycoplasma infection in couples attending a male infertility clinic | 27.3 | 0 | 2 |
| Is there a role for assisted reproductive technology in recurrent miscarriage? | 27.3 | 0 | 2 |
| Pathophysiology of varicocele in male infertility in the era of assisted reproductive technology | 27.3 | 0 | 2 |
| Multiple gestations/pregnancies from IVF process in a fertility center in Nigeria, 2009-2011: implementing policy towards fewer (double and single) embryo transfer | 27.3 | 0 | 2 |
| Fertility Treatment Decision-Making: The Effect of Insurance Coverage for Fertility Medications | 27.3 | 0 | 2 |
| In vitro maturation: a committee opinion | 27.3 | 0 | 2 |
| Informing offspring of their conception by gamete or embryo donation: a committee opinion | 27.3 | 0 | 2 |
| Ovarian stem cells—Potential roles in infertility treatment and fertility preservation | 27.3 | 0 | 2 |
| Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta-analysis | 27.3 | 0 | 2 |
| Progesterone luteal support after ovulation induction and intrauterine insemination: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| The wobbly evidence base of reproductive medicine | 27.3 | 0 | 2 |
| Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics | 27.3 | 0 | 2 |
| Misconduct in third-party assisted reproduction: a committee opinion | 27.3 | 0 | 2 |
| VACTERL association with hydrocephalus in a fetus conceived by in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Semen quality and prediction of IUI success in male subfertility: a systematic review | 27.3 | 0 | 2 |
| Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. | 27.3 | 0 | 2 |
| The use of in vitro fertilization in the management of male infertility: what the urologist needs to know | 27.3 | 0 | 2 |
| Patient-specific predictions of outcome after gonadotropin ovulation induction/intrauterine insemination | 27.3 | 0 | 2 |
| Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer | 27.3 | 0 | 2 |
| Cryopreservation and delayed embryo transfer-assisted reproductive technology registry and reporting implications | 27.3 | 0 | 2 |
| Efficacy and safety of intrauterine insemination and assisted reproductive technology in populations serodiscordant for human immunodeficiency virus: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Role of assisted hatching in in vitro fertilization: a guideline | 27.3 | 0 | 2 |
| Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion | 27.3 | 0 | 2 |
| Functional Sperm Testing and the Role of Proteomics in the Evaluation of Male Infertility | 27.3 | 0 | 2 |
| Assisted reproductive technology - IVF treatment in Ireland: A study of couples with successful outcomes | 27.3 | 0 | 2 |
| Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review | 27.3 | 0 | 2 |
| Disease spectrum and treatment patterns in a local male infertility clinic | 27.3 | 0 | 2 |
| The male infertility office visit | 27.3 | 0 | 2 |
| Methods employed to overcome difficult embryo transfer during assisted reproduction treatment | 27.3 | 0 | 2 |
| Role of tubal surgery in the era of assisted reproductive technology: a committee opinion | 27.3 | 0 | 2 |
| An Integrated Approach to Male-Factor Subfertility: Bridging the Gap Between Fertility Specialists Trained in Urology and Gynaecology | 27.3 | 0 | 2 |
| Who are we? A perspective on the reproductive endocrinologist and infertility specialist in the 21st century | 27.3 | 0 | 2 |
| Role of the mental health professional in education and support of the medical staff | 27.3 | 0 | 2 |
| Influence of female age on pregnancy outcome in in vitro fertilization and embryo transfer patients undergoing intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins | 27.3 | 0 | 2 |
| Subclinical hypothyroidism in the infertile female population: a guideline | 27.3 | 0 | 2 |
| The efficacy of intrauterine injection of human chorionic gonadotropin before embryo transfer in assisted reproductive cycles: Meta-analysis | 27.3 | 0 | 2 |
| Clinical significance of subclinical varicocelectomy in male infertility: systematic review and meta-analysis | 27.3 | 0 | 2 |
| Assisted reproductive technology in Australia and New Zealand: cumulative live birth rates as measures of success | 27.3 | 0 | 2 |
| Impact of equine assisted reproductive technologies (standard embryo transfer or intracytoplasmic sperm injection (ICSI) with in vitro culture and embryo transfer) on placenta and foal morphometry and placental gene expression. | 27.3 | 0 | 2 |
| Correct coding for laboratory procedures during assisted reproductive technology cycles | 27.3 | 0 | 2 |
| Sperm proteomics: potential impact on male infertility treatment. | 27.3 | 0 | 2 |
| Long-acting follicle-stimulating hormone versus daily follicle-stimulating hormone for women undergoing assisted reproduction | 27.3 | 0 | 2 |
| Lesbian, gay, bisexual, transgender content on reproductive endocrinology and infertility clinic websites | 27.3 | 0 | 2 |
| Freeze-only versus fresh embryo transfer in a multicenter matched cohort study: contribution of progesterone and maternal age to success rates | 27.3 | 0 | 2 |
| The effect of peri-implantation administration of uterine relaxing agents in assisted reproduction treatment cycles: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Maternal Racial and Ethnic Disparities in Neonatal Birth Outcomes With and Without Assisted Reproduction | 27.3 | 0 | 2 |
| Mature Oocyte Cryopreservation for Fertility Preservation | 27.3 | 0 | 2 |
| Chromosomal polymorphisms are associated with female infertility and adverse reproductive outcomes after infertility treatment: a 7-year retrospective study | 27.3 | 0 | 2 |
| Can we modify assisted reproductive technology practice to broaden reproductive care access? | 27.3 | 0 | 2 |
| Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility | 27.3 | 0 | 2 |
| Menopausal women requesting egg/embryo donation: examining health screening guidelines for assisted reproductive technology | 27.3 | 0 | 2 |
| A modified natural cycle results in higher live birth rate in vitrified-thawed embryo transfer for women with regular menstruation | 27.3 | 0 | 2 |
| Delayed intracytoplasmic sperm injection (ICSI) with trophectoderm biopsy and preimplantation genetic screening (PGS) show increased aneuploidy rates but can lead to live births with single thawed euploid embryo transfer (STEET). | 27.3 | 0 | 2 |
| A retrospective study of the effect of increasing age on success rates of assisted reproductive technology | 27.3 | 0 | 2 |
| Factors predicting double embryo implantation following double embryo transfer in assisted reproductive technology: implications for elective single embryo transfer | 27.3 | 0 | 2 |
| Guidance on the limits to the number of embryos to transfer: a committee opinion | 27.3 | 0 | 2 |
| Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology | 27.3 | 0 | 2 |
| Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers | 27.3 | 0 | 2 |
| The cutoff values of serum AMH levels and starting recFSH doses for the individualization of IVF treatment strategies | 27.3 | 0 | 2 |
| Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey | 27.3 | 0 | 2 |
| Emergent Oocyte Cryopreservation with a Novel Ovarian Transposition Technique in a Colorectal Cancer Patient: A Combined Approach for Fertility Preservation. A Case Report | 27.3 | 0 | 2 |
| What motivates men to offer sperm donation via the internet? | 27.3 | 0 | 2 |
| Oocyte cryopreservation for fertility preservation in women with cancer | 27.3 | 0 | 2 |
| The role of steroid hormone supplementation in non-assisted reproductive technology treatments for unexplained infertility | 27.3 | 0 | 2 |
| Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Assisted reproduction involving gestational surrogacy: an analysis of the medical, psychosocial and legal issues: experience from a large surrogacy program | 27.3 | 0 | 2 |
| Experience with 425 Subfertile Male Patients | 27.3 | 0 | 2 |
| Performing the embryo transfer: a guideline | 27.3 | 0 | 2 |
| Natural conception following total fertilization failure with intracytoplasmic sperm injection in a couple with unexplained infertility: a case report | 27.3 | 0 | 2 |
| Is subclinical hypothyroidism associated with lower live birth rates in women who have experienced unexplained recurrent miscarriage? | 27.3 | 0 | 2 |
| Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion | 27.3 | 0 | 2 |
| Population-based Semen Analysis Results and Fertility Among Patients With Inflammatory Bowel Disease: Results From Subfertility Health Assisted Reproduction and the Environment (SHARE) Study | 27.3 | 0 | 2 |
| Does ovulation induction and intrauterine insemination affect perinatal outcomes in singletons? | 27.3 | 0 | 2 |
| Effect of ethnicity on live birth rates after in vitro fertilisation/intracytoplasmic sperm injection treatment: analysis of UK national database | 27.3 | 0 | 2 |
| The use of donor sperm in the management of male infertility in Australia | 27.3 | 0 | 2 |
| Assisted reproductive technology: public funding and the voluntary shift to single embryo transfer in Australia | 27.3 | 0 | 2 |
| Normal birth after single-embryo transfer in a patient with excessive polypronuclear zygote formation following in vitro fertilization and intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation | 27.3 | 0 | 2 |
| Endometriosis, Ovarian Reserve and Live Birth Rate Following In Vitro Fertilization/Intracytoplasmic Sperm Injection | 27.3 | 0 | 2 |
| Assisted reproductive techniques in Latin America: the Latin American Registry, 2013 | 27.3 | 0 | 2 |
| Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report | 27.3 | 0 | 2 |
| High Peak Estradiol/Mature Oocyte Ratio Predicts Lower Clinical Pregnancy, Ongoing Pregnancy, and Live Birth Rates in GnRH Antagonist Intracytoplasmic Sperm Injection Cycles | 27.3 | 0 | 2 |
| Endometrial thickness significantly affects clinical pregnancy and live birth rates in frozen-thawed embryo transfer cycles | 27.3 | 0 | 2 |
| Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study | 27.3 | 0 | 2 |
| Determining the need for rescue intracytoplasmic sperm injection in partial fertilisation failure during a conventional IVF cycle | 27.3 | 0 | 2 |
| Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles | 27.3 | 0 | 2 |
| Clinical outcomes of frozen-thawed single blastocyst transfer in patients requiring whole embryo freezing | 27.3 | 0 | 2 |
| Does age of the sperm donor influence live birth outcome in assisted reproduction? | 27.3 | 0 | 2 |
| Position statement on West Nile virus: a committee opinion | 27.3 | 0 | 2 |
| Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? | 27.3 | 0 | 2 |
| Methods for detecting occupational causes of male infertility: reproductive history vs. semen analysis | 27.3 | 0 | 2 |
| Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer | 27.3 | 0 | 2 |
| Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma | 27.3 | 0 | 2 |
| How do cumulative live birth rates and cumulative multiple live birth rates over complete courses of assisted reproductive technology treatment per woman compare among registries? | 27.3 | 0 | 2 |
| The potential of intracytoplasmic sperm injection (ICSI) to transmit genetic defects causing male infertility. | 27.3 | 0 | 2 |
| Recommendations for practices utilizing gestational carriers: a committee opinion | 27.3 | 0 | 2 |
| Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction? | 27.3 | 0 | 2 |
| American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus | 27.3 | 0 | 2 |
| Fertility preservation and reproduction in cancer patients | 27.3 | 0 | 2 |
| Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes | 27.3 | 0 | 2 |
| Live birth rates are satisfactory following multiple IVF treatment cycles in poor prognosis patients. | 27.3 | 0 | 2 |
| The use of assisted reproduction technology (ART) for achieving conception in male infertility. | 27.3 | 0 | 2 |
| American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus | 27.3 | 0 | 2 |
| Risk of ectopic pregnancy is linked to endometrial thickness in a retrospective cohort study of 8120 assisted reproduction technology cycles | 27.3 | 0 | 2 |
| American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile Virus | 27.3 | 0 | 2 |
| Embryo quality is the main factor affecting cumulative live birth rate after elective single embryo transfer in fresh stimulation cycles | 27.3 | 0 | 2 |
| Chromatin fluorescence characteristics and standard semen analysis parameters: correlations observed in andrology testing among 136 males referred for infertility evaluation | 27.3 | 0 | 2 |
| Is there a future for ovulation induction in the current era of assisted reproduction? | 27.3 | 0 | 2 |
| Building a model to increase live birth rate through patient-specific optimization of embryo transfer day. | 27.3 | 0 | 2 |
| A survey of Irish consultants regarding awareness of sperm freezing and assisted reproduction. | 27.3 | 0 | 2 |
| Physical health of singleton children born after frozen embryo transfer using slow freezing: a 3-year follow-up study | 27.3 | 0 | 2 |
| The relationship between the changes in the level of progesterone and the outcome ofin vitrofertilization-embryo transfer | 27.3 | 0 | 2 |
| Do malignant diseases affect semen quality? Sperm parameters of men with cancers | 27.3 | 0 | 2 |
| Economic aspects of infertility care: a challenge for researchers and clinicians: Figure 1 | 27.3 | 0 | 2 |
| Position on reproductive donors and smallpox vaccine: a committee opinion | 27.3 | 0 | 2 |
| Management of secondary infertility following cesarean section: Report from the Subcommittee of the Reproductive Endocrinology Committee of the Japan Society of Obstetrics and Gynecology. | 27.3 | 0 | 2 |
| Klinefelter's syndrome in the male infertility clinic | 27.3 | 0 | 2 |
| Predictive value of sperm morphology and progressively motile sperm count for pregnancy outcomes in intrauterine insemination | 27.3 | 0 | 2 |
| Ovulation induction. Effects of ovulation induction with gonadotrophins on the ovary and uterus and their implications for assisted reproduction | 27.3 | 0 | 2 |
| The effects of ovulation induction with gonadotrophins on the ovary and uterus and implications for assisted reproduction | 27.3 | 0 | 2 |
| Hormonal and Clinical Predictors for Post-egg Retrieval Pain in Women Undergoing Assisted Reproductive Technology Procedures. | 27.3 | 0 | 2 |
| Is an animal model needed for intracytoplasmic sperm injection (ICSI) and other assisted reproduction technologies? | 27.3 | 0 | 2 |
| Stability of in vitro fertilization-embryo transfer success rates from the 1989, 1990, and 1991 Clinic-Specific Outcome Assessments | 27.3 | 0 | 2 |
| Current differences and consequences of legislation on practice of assisted reproductive technology in the Nordic countries. The Nordic Committee on Assisted Reproduction of the Scandinavian Federation of Societies of Obstetrics and Gynecology | 27.3 | 0 | 2 |
| The use of epididymal and testicular spermatozoa for intracytoplasmic sperm injection: the genetic implications for male infertility | 27.3 | 0 | 2 |
| Is it the egg or the endometrium? Elevated progesterone on day of trigger is not associated with embryo ploidy nor decreased success rates in subsequent embryo transfer cycles. | 27.3 | 0 | 2 |
| Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles | 27.3 | 0 | 2 |
| ROLE OF INTRA-UTERINE INSEMINATION AND SPERM PREPARATION TECHNIQUES IN TREATMENT OF UNEXPLAINED INFERTILITY AND MALE INFERTILITY | 27.3 | 0 | 2 |
| A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. | 27.3 | 0 | 2 |
| Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion | 27.3 | 0 | 2 |
| Is assisted reproduction the optimal treatment for varicocele-associated male infertility? A cost-effectiveness analysis | 27.3 | 0 | 2 |
| Male infertility treatment in the light of evidence-based medicine. | 27.3 | 0 | 2 |
| Safety in reproductive medicine: breadth, depth and discovery | 27.3 | 0 | 2 |
| Relationship between donor sperm parameters and pregnancy outcome after intrauterine insemination: analysis of 2821 cycles in 1355 couples. | 27.3 | 0 | 2 |
| N-acetyl cysteine in ovulation induction of PCOS women underwent intrauterine insemination: An RCT. | 27.3 | 0 | 2 |
| Sequential bilateral adnexal torsion after a single cycle of gonadotropin ovulation induction with intrauterine insemination. | 27.3 | 0 | 2 |
| Pregnancy rates with intrauterine insemination: comparing 1999 and 2010 World Health Organization semen analysis norms | 27.3 | 0 | 2 |
| Effect of male body mass index on clinical outcomes following assisted reproductive technology: a meta-analysis | 27.3 | 0 | 2 |
| Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle. | 27.3 | 0 | 2 |
| Assisted reproductive techniques in single women: Which proposals for which demands? | 27.3 | 0 | 2 |
| In vivo survival of domestic cat oocytes after vitrification, intracytoplasmic sperm injection and embryo transfer | 27.3 | 0 | 2 |
| Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure | 27.3 | 0 | 2 |
| Economic evaluation of elective single-embryo transfer with subsequent single frozen embryo transfer in an in vitro fertilization/intracytoplasmic sperm injection program | 27.3 | 0 | 2 |
| Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows | 27.3 | 0 | 2 |
| The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis | 27.3 | 0 | 2 |
| The practical application of genetics in the male infertility clinic | 27.3 | 0 | 2 |
| Intrauterine insemination for treatment of male infertility | 27.3 | 0 | 2 |
| Effect of embryo freezing on perinatal outcome after assisted reproduction techniques: lessons from the Latin American Registry of Assisted Reproduction | 27.3 | 0 | 2 |
| Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion | 27.3 | 0 | 2 |
| Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion | 27.3 | 0 | 2 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 27.3 | 0 | 2 |
| Ovarian Pregnancy following Intracytoplasmic Sperm Injection and Embryo Transfer: A Case Report | 27.3 | 0 | 2 |
| Are intracytoplasmic sperm injection and high serum estradiol compounding risk factors for adverse obstetric outcomes in assisted reproductive technology? | 27.3 | 0 | 2 |
| Male infertility clinic - Is it useful? | 27.3 | 0 | 2 |
| Fertility Treatments in the United States: Improving Access and Outcomes | 27.3 | 0 | 2 |
| Viability of cumulus cells is associated with basal AMH levels in assisted reproduction. | 27.3 | 0 | 2 |
| Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression | 27.3 | 0 | 2 |
| Further evidence supports the clinical utility of sperm DNA fragmentation testing in male infertility workup and assisted reproductive technology | 27.3 | 0 | 2 |
| IVF Treatment and Single Embryo Transfer | 27.3 | 0 | 2 |
| Effect of high-dose estrogen in luteal phase support on live birth rates after assisted reproduction treatment cycles | 27.3 | 0 | 2 |
| The Use of Ultrasound during Intrauterine Insemination in Unexplained Infertility May Improve Pregnancy Outcomes | 27.3 | 0 | 2 |
| Aspirin alone or combined with nadroparin did not increase live birth rates in women with unexplained recurrent miscarriage | 27.3 | 0 | 2 |
| Comparison of Alarelin and Triptorelin in the long-protocol ovulation induction in in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Assisted reproduction: an important review of the literature on the risk of malformation after in vitro fertilization and intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study | 27.3 | 0 | 2 |
| Natural cycle versus ovulation induction cycle in intrauterine insemination | 27.3 | 0 | 2 |
| Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study. | 27.3 | 0 | 2 |
| Cryopreserved oocytes can serve as the treatment for secondary infertility: a novel model for egg donation | 27.3 | 0 | 2 |
| Antral follicle count as a predictor of hyperresponse in controlled ovarian hyperstimulation/intrauterine insemination in unexplained sterility | 27.3 | 0 | 2 |
| Oocyte cryopreservation after controlled ovarian hyperstimulation in mosaic Turner syndrome: another fertility preservation option in a dedicated UK clinic | 27.3 | 0 | 2 |
| Successful pregnancy with frozen embryo transfer into a gestational carrier from eggs obtained from a woman in premature menopause | 27.3 | 0 | 2 |
| Comparison of the Outcome of Conventional in vitro Fertilization and Intracytoplasmic Sperm Injection in Moderate Male Infertility from Ejaculate | 27.3 | 0 | 2 |
| Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction | 27.3 | 0 | 2 |
| Comparison of aneuploidy, pregnancy and live birth rates between day 5 and day 6 blastocysts | 27.3 | 0 | 2 |
| Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit | 27.3 | 0 | 2 |
| Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Repetitive oocyte donation: a committee opinion | 27.3 | 0 | 2 |
| Is there really no improvement in pregnancy rate with double intrauterine insemination in unexplained infertility? | 27.3 | 0 | 2 |
| Semen analysis parameters: experiences and insight into male infertility at a tertiary care hospital in Punjab | 27.3 | 0 | 2 |
| Prediction of success in intracytoplasmic sperm injection (ICSI) by estimation of serum estradiol/progesterone ratio on the day of embryo transfer | 27.3 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 27.3 | 0 | 2 |
| Life after unsuccessful IVF treatment in an assisted reproduction unit: a qualitative analysis of gains through loss among Chinese persons in Hong Kong. | 27.3 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 27.3 | 0 | 2 |
| Role of capacitation in intrauterine insemination as a treatment of male infertility | 27.3 | 0 | 2 |
| Intrauterine insemination using cryopreserved donor sperm, a methods which increases therapeutic success | 27.3 | 0 | 2 |
| Estimation of the Contribution of Assisted and Non-Assisted Reproductive Technology Fertility Treatments to Multiple Births During the Past 30 Years in Japan: 1979–2008 | 27.3 | 0 | 2 |
| Perinatal outcomes after assisted reproductive technology treatment in Australia and New Zealand: single versus double embryo transfer. | 27.3 | 0 | 2 |
| A comparative study of single-dose growth hormone therapy as an adjuvant to gonadotrophin treatment for ovulation induction | 27.3 | 0 | 2 |
| Role of semen analysis in subfertile couples | 27.3 | 0 | 2 |
| Anthropometric measurements in infants conceived by assisted reproductive techniques versus spontaneous conception | 27.3 | 0 | 2 |
| Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage | 27.3 | 0 | 2 |
| The effect of smoking on infertility treatment in women undergoing assisted reproduction cycles | 27.3 | 0 | 2 |
| Ovarian stimulation in intrauterine insemination with donor sperm: a randomized study comparing clomiphene citrate in fixed protocol versus highly purified urinary FSH. | 27.3 | 0 | 2 |
| Semen analysis in adolescent cancer patients prior to bone marrow transplantation: when is it too late for fertility preservation? | 27.3 | 0 | 2 |
| Intrauterine insemination with frozen donor sperm. Pregnancy outcome in relation to age and ovarian stimulation regime | 27.3 | 0 | 2 |
| Luteinized unruptured follicle syndrome: incidence and recurrence rate in infertile women with unexplained infertility undergoing intrauterine insemination | 27.3 | 0 | 2 |
| Follicular fluid-induced acrosome reaction distinguishes a subgroup of men with unexplained infertility not identified by semen analysis | 27.3 | 0 | 2 |
| Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| A Clinical Investigation of the Role of the Semen Analysis and Postcoital Test in the Evaluation of Male Infertility | 27.3 | 0 | 2 |
| Distribution of male infertility specialists in relation to the male population and assisted reproductive technology centers in the United States | 27.3 | 0 | 2 |
| Parental attitudes toward fertility preservation in boys with cancer: context of different risk levels of infertility and success rates of fertility restoration | 27.3 | 0 | 2 |
| Impact of high response of ovary to gonadotropin stimulation on the outcome of in vitro fertilization and embryo transfer or intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Oocyte or embryo donation to women of advanced age: a committee opinion | 27.3 | 0 | 2 |
| Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. | 27.3 | 0 | 2 |
| The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment | 27.3 | 0 | 2 |
| Immunosuppressant material in human seminal fluid. Inhibition of blast transformation and of NK activity by seminal fluid patients of a male infertility clinic | 27.3 | 0 | 2 |
| Female infertility. Medically assisted reproduction | 27.3 | 0 | 2 |
| Effect of ethnicity on live birth rates after in vitro fertilisation or intracytoplasmic sperm injection treatment: possible explanations and further observations | 27.3 | 0 | 2 |
| Human oocyte cryopreservation as an adjunct to IVF-embryo transfer cycles | 27.3 | 0 | 2 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 27.3 | 0 | 2 |
| High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2) | 27.3 | 0 | 2 |
| A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively | 27.3 | 0 | 2 |
| Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE | 27.3 | 0 | 2 |
| Twin pregnancy outcome among cases of spontaneous conception, intrauterine insemination, and in vitro fertilization/intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Re: Distribution of Male Infertility Specialists in Relation to the Male Population and Assisted Reproductive Technology Centers in the United States | 27.3 | 0 | 2 |
| Laparoscopic treatment of recurrent ectopic pregnancy in the ipsilateral salpinx after ovulation induction and intrauterine insemination | 27.3 | 0 | 2 |
| Defining embryo donation: a committee opinion | 27.3 | 0 | 2 |
| Place of intracytoplasmic sperm injection in management of male infertility | 27.3 | 0 | 2 |
| Outcome of intracytoplasmic sperm injection in azoospermic patients: stressing the liaison between the urologist and reproductive medicine specialist | 27.3 | 0 | 2 |
| Transvaginal intratubal embryo transfer: a new treatment of male infertility | 27.3 | 0 | 2 |
| Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience | 27.3 | 0 | 2 |
| Assessment of male infertility: correlation between results of semen analysis and phosphorus-31 magnetic resonance spectroscopy | 27.3 | 0 | 2 |
| Live birth rate in fresh and frozen embryo transfer cycles in women with endometriosis. | 27.3 | 0 | 2 |
| Is there any place for oocyte cryopreservation after cancer treatment? | 27.3 | 0 | 2 |
| Authors' reply: Effect of ethnicity on live birth rates after in vitro fertilisation or intracytoplasmic sperm injection treatment: possible explanations and further observations. | 27.3 | 0 | 2 |
| Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database | 27.3 | 0 | 2 |
| Effects of coasting on the outcome of intracytoplasmic sperm injection-embryo transfer cycles | 27.3 | 0 | 2 |
| Ovulation induction for assisted reproduction | 27.3 | 0 | 2 |
| The effects of ovulation induction during infertility treatment on gingival inflammation | 27.3 | 0 | 2 |
| Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility | 27.3 | 0 | 2 |
| Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine | 27.3 | 0 | 2 |
| Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel’s commentary ‘Evidenced-based medicine and the role of the National Health Service in assisted reproduction’ | 27.3 | 0 | 2 |
| Paternal body mass index is associated with decreased blastocyst development and reduced live birth rates following assisted reproductive technology | 27.3 | 0 | 2 |
| IL-18 levels in the semen of male infertility: Semen analysis | 27.3 | 0 | 2 |
| Risk-sharing or refund programs in assisted reproduction: a committee opinion | 27.3 | 0 | 2 |
| Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility. | 27.3 | 0 | 2 |
| Reproductive medicine and the law: egg donation in Germany, Spain and other European countries | 27.3 | 0 | 2 |
| Possible improvement of depression after systematic examination and explanation of live birth rates among women with recurrent miscarriage. | 27.3 | 0 | 2 |
| Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature? | 27.3 | 0 | 2 |
| Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial | 27.3 | 0 | 2 |
| Double versus single intrauterine insemination for unexplained infertility: a meta-analysis of randomized trials | 27.3 | 0 | 2 |
| Sperm washing and intrauterine insemination for cervical factor, oligospermia, immunologic infertility and unexplained infertility | 27.3 | 0 | 2 |
| Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment | 27.3 | 0 | 2 |
| Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial | 27.3 | 0 | 2 |
| First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient | 27.3 | 0 | 2 |
| Comparison of the efficacy of treating sperm with low hypoosmotic swelling test scores with chymotrypsin followed by intrauterine insemination vs in vitro fertilization with intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 27.3 | 0 | 2 |
| Does the timing of mock embryo transfer trial improve implantation in intracytoplasmic sperm injection cycles? | 27.3 | 0 | 2 |
| Comparison of the semen analysis results obtained from two branded computer-aided sperm analysis systems | 27.3 | 0 | 2 |
| Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 27.3 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 27.3 | 0 | 2 |
| Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 27.3 | 0 | 2 |
| Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 27.3 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 27.3 | 0 | 2 |
| Prevention of first-trimester miscarriage with dextroamphetamine sulfate treatment in women with recurrent miscarriage following embryo transfer -- case report | 27.3 | 0 | 2 |
| Vaccination guidelines for female infertility patients: a committee opinion | 27.3 | 0 | 2 |
| Predicting pregnancy rate and live birth rate in the IVF clinic by analysing patient profiles | 27.3 | 0 | 2 |
| More Options for Fertility Preservation for Patients With Cancer | 27.3 | 0 | 2 |
| Guidelines on number of embryos transferred | 27.3 | 0 | 2 |
| Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic g | 27.3 | 0 | 2 |
| Genetic risks of intracytoplasmic sperm injection in the treatment of male infertility: recommendations for genetic counseling and screening | 27.3 | 0 | 2 |
| Public policy aspects of assisted reproduction. Vth World Congress, IVF and embryo transfer | 27.3 | 0 | 2 |
| Luteal phase progesterone increases live birth rate after frozen embryo transfer | 27.3 | 0 | 2 |
| Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology? | 27.3 | 0 | 2 |
| Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility | 27.3 | 0 | 2 |
| Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin | 27.3 | 0 | 2 |
| Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Repo | 27.3 | 0 | 2 |
| Trends and factors associated with the Day 5 embryo transfer, assisted reproductive technology surveillance, USA, 2001-2009. | 27.3 | 0 | 2 |
| Need for Comprehensive Counseling in Women Requesting Oocyte Cryopreservation | 27.3 | 0 | 2 |
| Intrauterine insemination of cultured peripheral blood mononuclear cells prior to embryo transfer improves clinical outcome for patients with repeated implantation failures | 27.3 | 0 | 2 |
| Intrauterine insemination with washed capacitated sperm cells in the treatment of male factor, cervical factor and unexplained infertility. | 27.3 | 0 | 2 |
| Analysis of pregnancy outcomes after in vitro fertilization-embryo transfer and intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Pregnancy with 15 live fetuses and severe ovarian hyperstimulation syndrome after ovulation induction and intrauterine insemination | 27.3 | 0 | 2 |
| Intracytoplasmic sperm injection and conventional in vitro fertilization for sibling oocytes in cases of unexplained infertility and borderline semen | 27.3 | 0 | 2 |
| Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction | 27.3 | 0 | 2 |
| Ovarian superstimulation and intrauterine insemination for the treatment of unexplained infertility | 27.3 | 0 | 2 |
| Retracted article: Clomiphene citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized trial | 27.3 | 0 | 2 |
| Randomized controlled trial of three doses of letrozole for ovulation induction in patients with unexplained infertility | 27.3 | 0 | 2 |
| Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer? | 27.3 | 0 | 2 |
| Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey | 27.3 | 0 | 2 |
| Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle | 27.3 | 0 | 2 |
| Embryo transfer practices in the United States: a survey of clinics registered with the Society for Assisted Reproductive Technology | 27.3 | 0 | 2 |
| Posthumous assisted reproduction: a survey of attitudes of couples seeking fertility treatment and the degree of agreement between intimate partners | 27.3 | 0 | 2 |
| Prospective randomized study for hydrotubation versus no hydrotubation before intrauterine insemination in unexplained infertility | 27.3 | 0 | 2 |
| Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria. | 27.3 | 0 | 2 |
| Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program | 27.3 | 0 | 2 |
| Factors predictive of clinical pregnancy in the first intrauterine insemination cycle of 306 couples with favourable female patient characteristics | 27.3 | 0 | 2 |
| Factors associated with dizygotic twinning after IVF treatment with double embryo transfer | 27.3 | 0 | 2 |
| Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? | 27.3 | 0 | 2 |
| Treatment period and medical care costs to achieve the first live birth by assisted reproductive technology are lower in the single embryo transfer period than in the double embryo transfer period: a retrospective analysis of women younger than 40 y | 27.3 | 0 | 2 |
| The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination | 27.3 | 0 | 2 |
| Ovulation induction increases pregnancy rate during intrauterine insemination compared with natural cycles | 27.3 | 0 | 2 |
| Cross-border reproductive care: a committee opinion | 27.3 | 0 | 2 |
| Racial Disparities in Fertility Care: an Analysis of 4537 Intrauterine Insemination Cycles | 27.3 | 0 | 2 |
| An analysis of the impact of embryo transfer difficulty on live birth rates, using a standardised grading system | 27.3 | 0 | 2 |
| Relationship between follicle number and (multiple) live birth rate after controlled ovarian hyperstimulation and intrauterine insemination | 27.3 | 0 | 2 |
| Effects of Biovar I and Biovar II of Ureaplasma urealyticum on Sperm Parameters, Lipid Peroxidation, and Deoxyribonucleic Acid Damage in Male Infertility | 27.3 | 0 | 2 |
| No increase in autism-associated genetic events in children conceived by assisted reproduction | 27.3 | 0 | 2 |
| Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 27.3 | 0 | 2 |
| Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and in | 27.3 | 0 | 2 |
| Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion | 27.3 | 0 | 2 |
| Role of antral follicle count in controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unexplained subfertility | 27.3 | 0 | 2 |
| A controlled study between the use of gamete intrafallopian transfer (GIFT) and in vitro fertilization and embryo transfer in the management of idiopathic and male infertility | 27.3 | 0 | 2 |
| Significance of positive semen culture in relation to male infertility and the assisted reproductive technology process | 27.3 | 0 | 2 |
| Ovulation induction/intrauterine insemination in infertile couples is associated with low-birth-weight infants | 27.3 | 0 | 2 |
| Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society for Assisted Reproductive Technology | 27.3 | 0 | 2 |
| Medical egg freezing: the importance of a patient-centered approach to fertility preservation | 27.3 | 0 | 2 |
| Medical egg freezing and cancer patients' hopes: Fertility preservation at the intersection of life and death | 27.3 | 0 | 2 |
| Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial | 27.3 | 0 | 2 |
| Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women | 27.3 | 0 | 2 |
| Assisted Reproductive Technology with Donor Sperm: National Trends and Perinatal Outcomes | 27.3 | 0 | 2 |
| Assisted reproductive technology (ART) cumulative live birth rates following preimplantation genetic diagnosis for aneuploidy (PGD-A) or morphological assessment of embryos: A cohort analysis. | 27.3 | 0 | 2 |
| Reprotoxicity of intrauterine insemination and in vitro fertilization-embryo transfer disposables and products: a 4-year survey | 27.3 | 0 | 2 |
| Stimulation of endometrium embryo transfer can improve implantation and pregnancy rates for patients undergoing assisted reproductive technology for the first time with a high-grade blastocyst | 27.3 | 0 | 2 |
| Congenital Malformations in Singleton Infants Conceived by Assisted Reproductive Technologies and Singleton Infants by Natural Conception in Tehran, Iran | 27.3 | 0 | 2 |
| Oocyte Cryopreservation for Fertility Preservation in Healthy Women | 27.3 | 0 | 2 |
| Committee opinion No. 532: compounded bioidentical menopausal hormone therapy | 27.3 | 0 | 2 |
| Knowledge, attitudes, and intentions toward fertility awareness and oocyte cryopreservation among obstetrics and gynecology resident physicians | 27.3 | 0 | 2 |
| Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial | 27.3 | 0 | 2 |
| Living Kinship Trouble: Danish Sperm Donors’ Narratives of Relatedness | 27.3 | 0 | 2 |
| Cumulative pregnancy and live birth rates through assisted reproduction in women 44-45 years of age: is there any hope? | 27.3 | 0 | 2 |
| Live birth rates after combined adjuvant therapy in IVF–ICSI cycles: a matched case-control study | 27.3 | 0 | 2 |
| The Effect of Instant Urinary Catheterization on Pregnancy Outcomes after Intracytoplasmic Sperm Injection and Embryo Transfer | 27.3 | 0 | 2 |
| Association Between Pesticide Residue Intake From Consumption of Fruits and Vegetables and Pregnancy Outcomes Among Women Undergoing Infertility Treatment With Assisted Reproductive Technology | 27.3 | 0 | 2 |
| The Importance of the Periconception Period: Immediate Effects in Cattle Breeding and in Assisted Reproduction Such as Artificial Insemination and Embryo Transfer | 27.3 | 0 | 2 |
| Cross-border reproductive care: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Evaluation of trend in semen analysis for 11 years in subjects attending a fertility clinic in India. | 27.3 | 0 | 2 |
| Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion | 27.3 | 0 | 2 |
| The impact of the new Turkish regulation, imposing single embryo transfer after assisted reproduction technology, on neonatal intensive care unit utilization: a single center experience. | 27.3 | 0 | 2 |
| Donor Motivations, Associated Risks and Ethical Considerations of Oocyte Donation | 27.3 | 0 | 2 |
| RETIRED: Defining embryo donation: an Ethics Committee opinion | 27.3 | 0 | 2 |
| First line fertility treatment strategies regarding IUI and IVF require clinical evidence | 27.3 | 0 | 2 |
| Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry | 27.3 | 0 | 2 |
| Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 27.3 | 0 | 2 |
| Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 27.3 | 0 | 2 |
| Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 27.3 | 0 | 2 |
| A Focus on Maternal Health Before Assisted Reproduction: Results From a Pilot Survey of Canadian IVF Medical Directors | 27.3 | 0 | 2 |
| Effect of male body mass index on live-birth sex ratio of singletons after assisted reproduction technology | 27.3 | 0 | 2 |
| Assisted reproductive technology in reproductive medicine - possibilities and limitations | 27.3 | 0 | 2 |
| Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India | 27.3 | 0 | 2 |
| Consideration of the gestational carrier: a committee opinion | 27.3 | 0 | 2 |
| The use of luteal-phase ovarian stimulation for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment | 27.3 | 0 | 2 |
| Effect of premature serum progesterone rise on embryo transfer outcomes and the role of blastocyst culture and transfer in assisted reproductive technology cycles with premature progesterone rise | 27.3 | 0 | 2 |
| A pilot study of gonadotrophin releasing hormone agonist (GnRHa)/superovulation/donor intrauterine insemination (IUI) after unsuccessful artificial insemination with donor sperm (DI). | 27.3 | 0 | 2 |
| The influence of male age on treatment outcomes and neonatal birthweight following assisted reproduction technology involving intracytoplasmic sperm injection (ICSI) cycles. | 27.3 | 0 | 2 |
| Elevated serum estradiol levels in artificial autologous frozen embryo transfer cycles negatively impact ongoing pregnancy and live birth rates | 27.3 | 0 | 2 |
| Quality of information about success rates provided on assisted reproductive technology clinic websites in Australia and New Zealand. | 27.3 | 0 | 2 |
| Ovulation induction and oocyte retrieval for fertility preservation in young adolescents newly diagnosed with medulloblastoma: a case series | 27.3 | 0 | 2 |
| Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment? | 27.3 | 0 | 2 |
| Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures. | 27.3 | 0 | 2 |
| Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology outcomes between 2004 and 2013. | 27.3 | 0 | 2 |
| Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation | 27.3 | 0 | 2 |
| Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort | 27.3 | 0 | 2 |
| Use of donor sperm in addition to oocyte donation after repeated implantation failure in normozoospermic patients does not improve live birth rates | 27.3 | 0 | 2 |
| Pregnancy after intracytoplasmic sperm injection following extended sperm preparation and hormone therapy in an azoospermic man with maturation arrest and microlithiasis: a case report and literature review | 27.3 | 0 | 2 |
| American Society for Reproductive Medicine Updates Consent Forms for Egg Donation | 27.3 | 0 | 2 |
| Fertility Preservation Through Oocyte Cryopreservation in a Patient with Ovarian Dysgerminocarcinoma: A Case Report | 27.3 | 0 | 2 |
| Association among diameter and volume of follicles, oocyte maturity, and competence in intracytoplasmic sperm injection cycles | 27.3 | 0 | 2 |
| Live birth rates after IVF are lower with frozen donor eggs, study shows: | 27.3 | 0 | 2 |
| Left Out in the Cold: Arguments Against Non-Medical Oocyte Cryopreservation | 27.3 | 0 | 2 |
| Live birth rate with repeat microdissection TESE and intracytoplasmic sperm injection after a conventional testicular biopsy in men with nonobstructive azoospermia | 27.3 | 0 | 2 |
| Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure | 27.3 | 0 | 2 |
| Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer | 27.3 | 0 | 2 |
| The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial | 27.3 | 0 | 2 |
| Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET | 27.3 | 0 | 2 |
| Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion | 27.3 | 0 | 2 |
| Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology | 27.3 | 0 | 2 |
| Can intracytoplasmic sperm injection prevent total fertilization failure and enhance embryo quality in patients with non-male factor infertility? | 27.3 | 0 | 2 |
| The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patients | 27.3 | 0 | 2 |
| The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction technology | 27.3 | 0 | 2 |
| Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome | 27.3 | 0 | 2 |
| Fertility preservation utilizing controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome | 27.3 | 0 | 2 |
| Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure | 27.3 | 0 | 2 |
| Comparison of pregnancy outcome following frozen embryo transfer (ET) in a gestational carrier program according to source of the oocytes | 27.3 | 0 | 2 |
| Double embryo transfer gives good pregnancy and live birth rates in poor responders with a modest increase in multiple birth rates: results from an observational study | 27.3 | 0 | 2 |
| Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates | 27.3 | 0 | 2 |
| Successful pregnancy following oocyte activation by strontium in normozoospermic patients of unexplained infertility with fertilisation failures during previous intracytoplasmic sperm injection treatment | 27.3 | 0 | 2 |
| Fertilization by intracytoplasmic sperm injection with sperm with subnormal morphology using strict criteria results in lower live delivered pregnancy rates following frozen embryo transfer rather than eggs fertilized conventionally | 27.3 | 0 | 2 |
| Pregnancy rates per embryo transfer (ET) may be improved by conventional oocyte insemination for male factor rather than intracytoplasmic sperm injection (ICSI). | 27.3 | 0 | 2 |
| Conventional oocyte insemination may result in a better pregnancy outcome than intracytoplasmic sperm injection (ICSI) for unexplained infertility. | 27.3 | 0 | 2 |
| Round spermatid nucleus injection (ROSNI). | 27.3 | 0 | 2 |
| Revised minimum standards for practices offering assisted reproductive technologies | 27.3 | 0 | 2 |
| Comparative study of intracytoplasmic sperm injection and in vitro fertilization with high insemination concentration in sibling oocytes in the treatment of unexplained infertility. | 27.3 | 0 | 2 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 27.3 | 0 | 2 |
| What is the best time to perform intracytoplasmic sperm injection/embryo transfer cycle after hysteroscopic surgery for an incomplete uterine septum? | 27.3 | 0 | 2 |
| Patterns of intracellular calcium oscillations in horse oocytes fertilized by intracytoplasmic sperm injection: possible explanations for the low success of this assisted reproduction technique in the horse. | 27.3 | 0 | 2 |
| Day 2 vs. day 3 embryo transfer after intracytoplasmic sperm injection. A prospective, randomized study | 27.3 | 0 | 2 |
| Effect of ovarian cysts detected on the beginning day of ovulation induction to the success rates in ART cycles | 27.3 | 0 | 2 |
| Mouse ICSI with frozen-thawed sperm: the impact of sperm freezing procedure and sperm donor strain | 27.3 | 0 | 2 |
| Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births | 27.3 | 0 | 2 |
| Assisted reproduction technique outcomes for fresh versus deferred cryopreserved day-2 embryo transfer: a retrospective matched cohort study | 27.3 | 0 | 2 |
| Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer | 27.3 | 0 | 2 |
| The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Clinical application of intracytoplasmic sperm injection using in vitro cultured testicular spermatozoa obtained the day before egg retrieval | 27.3 | 0 | 2 |
| Multinucleation in normally fertilized embryos is associated with an accelerated ovulation induction response and lower implantation and pregnancy rates in in vitro fertilization-embryo transfer cycles | 27.3 | 0 | 2 |
| Intracytoplasmic sperm injection into oocytes of severe male infertility patients: UAMS experience. University of Arkansas for Medical Sciences | 27.3 | 0 | 2 |
| Pregnancy After Human Donor Oocyte Cryopreservation and Thawing in Association with Intracytoplasmic Sperm Injection in a Patient with Ovarian Failure | 27.3 | 0 | 2 |
| The effect of female age and ovarian reserve on pregnancy rate in male infertility: treatment of azoospermia with sperm retrieval and intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| The impact of endometriosis in couples undergoing intracytoplasmic sperm injection because of male infertility | 27.3 | 0 | 2 |
| The geriatric gravida: Multifetal pregnancy reduction, donor eggs, and aggressive infertility treatments | 27.3 | 0 | 2 |
| Panel two: reporting and advertising success rates--the Gordian Knot of assisted reproductive technology. The role of professional societies | 27.3 | 0 | 2 |
| Ethical issues of egg donation | 27.3 | 0 | 2 |
| Effect of levothyroxine on live birth rate in euthyroid women with recurrent miscarriage and TPO antibodies (T4-LIFE study). | 27.3 | 0 | 2 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 27.3 | 0 | 2 |
| Warning note on male infertility treatment. | 27.3 | 0 | 2 |
| Submicroscopic mathematical evaluation of spermatozoa in assisted reproduction. I. Intracytoplasmic sperm injection. (Notulae seminologicae 6) | 27.3 | 0 | 2 |
| Cross-border reproductive care for law evasion: a qualitative study into the experiences and moral perspectives of French women who go to Belgium for treatment with donor sperm. | 27.3 | 0 | 2 |
| Extraterritoriality for cross-border reproductive care: should states act against citizens travelling abroad for illegal infertility treatment? | 27.3 | 0 | 2 |
| Factors of importance for the establishment of a successful program of intracytoplasmic sperm injection treatment for male infertility. | 27.3 | 0 | 2 |
| The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. | 27.3 | 0 | 2 |
| The use of intracytoplasmic sperm injection for the treatment of severe and extreme male infertility | 27.3 | 0 | 2 |
| Intracytoplasmic sperm injection--clinical results from the reproductive medicine unit, Adelaide | 27.3 | 0 | 2 |
| Controversies in assisted reproduction: oocyte donation. Protocols for egg donation | 27.3 | 0 | 2 |
| Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization/embryo transfer with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin | 27.3 | 0 | 2 |
| Outcome of donor versus husband insemination in couples with unexplained infertility treated by in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Women's attitude to egg donation and sperm donation -- a cross cultural study | 27.3 | 0 | 2 |
| Possibilities and limitations of techniques of assisted reproduction for the treatment of male infertility | 27.3 | 0 | 2 |
| The significance of 17 beta-estradiol levels in highly responding women during ovulation induction in IVF treatment: its impact and prognostic value with respect to oocyte maturation and treatment outcome | 27.3 | 0 | 2 |
| A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program | 27.3 | 0 | 2 |
| Birthweight of singletons after assisted reproduction is higher after single- than after double-embryo transfer | 27.3 | 0 | 2 |
| Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer | 27.3 | 0 | 2 |
| Intrauterine insemination versus intracervical insemination in donor sperm treatment | 27.3 | 0 | 2 |
| Effect of the sexual abstinence period recommended by the World Health Organization on clinical outcomes of fresh embryo transfer cycles with normal ovarian response after intracytoplasmic sperm injection. | 27.3 | 0 | 2 |
| Day 4 good morula embryo transfer provided compatible live birth rate with day 5 blastocyst embryo in fresh IVF/ET cycles | 27.3 | 0 | 2 |
| Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial | 27.3 | 0 | 2 |
| Reproductive endocrinology: Postmenopausal hormone therapy to prevent chronic conditions | 27.3 | 0 | 2 |
| Texas Fertility Center | 27.3 | 0 | 2 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 27.3 | 0 | 2 |
| Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013. | 27.3 | 0 | 2 |
| Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction? | 27.3 | 0 | 2 |
| On the Origins of the Semen Analysis: A Close Relationship with the History of the Reproductive Medicine | 27.3 | 0 | 2 |
| Gestational carrier in assisted reproductive technology | 27.3 | 0 | 2 |
| Successful pregnancy following intracytoplasmic sperm injection?embryo transfer in a patient with premature ovarian insufficiency: a case report | 27.3 | 0 | 2 |
| Assisted reproductive technology : strategies of elective single embryo transfer | 27.3 | 0 | 2 |
| Donor sperm insemination after failed intra-couple intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Do trained reproductive endocrinologists perform better than their trainees? Comparing clinical pregnancy rates and live birth rates after transfer of single fresh blastocysts. | 27.3 | 0 | 2 |
| Comparison of embryo transfer strategies and assisted reproduction outcome in Slovenian and cross-border patients | 27.3 | 0 | 2 |
| Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline | 27.3 | 0 | 2 |
| CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer | 27.3 | 0 | 2 |
| The impact of food intake and social habits on embryo quality and the likelihood of blastocyst formation | 27.3 | 0 | 2 |
| Bioethical dilemmas of assisted reproduction in the opinions of Polish women in infertility treatment: a research report | 27.3 | 0 | 2 |
| Costs of medically assisted reproduction treatment at specialized fertility clinics in the Danish public health care system: results from a 5-year follow-up cohort study | 27.3 | 0 | 2 |
| Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers | 27.3 | 0 | 2 |
| Congenital bilateral absence of the vas deferens: the impact of spermatogenesis quality on intracytoplasmic sperm injection outcomes in 108 men | 27.3 | 0 | 2 |
| Does progesterone supplementation improve pregnancy rates in clomiphene citrate and intrauterine insemination treatment cycles? | 27.3 | 0 | 2 |
| The effect of endometrial thickness on in vitro fertilization (IVF)-embryo transfer/intracytoplasmic sperm injection (ICSI) outcome | 27.3 | 0 | 2 |
| Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization/intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| An online survey of specialists’ opinion on first line management options for unexplained subfertility | 27.3 | 0 | 2 |
| Fertilization by intracytoplasmic sperm injection (ICSI) does not impair subsequent pregnancy outcome following frozen embryo transfer (ET) as determined by a large retrospective analysis | 27.3 | 0 | 2 |
| Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles | 27.3 | 0 | 2 |
| Elements to be considered in obtaining informed consent for ART. | 27.3 | 0 | 2 |
| Semen quality of consecutive ejaculates from cancer patients for fertility preservation | 27.3 | 0 | 2 |
| Reciprocal oocyte sharing in return for altruistic sperm donation to fulfill the demands of clinical assisted reproduction and somatic cell nuclear transfer (SCNT) research | 27.3 | 0 | 2 |
| Evaluation of ovulation induction protocols for poor responders undergoing assisted reproduction techniques. | 27.3 | 0 | 2 |
| Use of fetal oocytes in assisted reproduction | 27.3 | 0 | 2 |
| A strategy for treatment of couples with unexplained infertility who failed to conceive after intrauterine insemination | 27.3 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction | 27.3 | 0 | 2 |
| Attitudes toward embryo donation among staff at in vitro fertilization clinics | 27.3 | 0 | 2 |
| Perinatal outcomes of intrauterine insemination/clomiphene pregnancies represent an intermediate risk group compared with in vitro fertilisation/intracytoplasmic sperm injection and naturally conceived pregnancies | 27.3 | 0 | 2 |
| The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Fallopian tube sperm perfusion versus intrauterine insemination in unexplained infertility: a randomized, prospective, cross-over trial | 27.3 | 0 | 2 |
| Superfetation after ovulation induction and intrauterine insemination performed during an unknown ectopic pregnancy | 27.3 | 0 | 2 |
| Recent advances in female infertility care | 27.3 | 0 | 2 |
| Treatment of patients with unexplained infertility: gamete intrafallopian transfer (GIFT) versus tubal embryo transfer (TET) | 27.3 | 0 | 2 |
| Practice patterns among reproductive endocrinologists: further aspects of the infertility evaluation. | 27.3 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 27.3 | 0 | 2 |
| Incidence of chromosomal aberrations in children born after assisted reproduction through intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Practice patterns among reproductive endocrinologists: the infertility evaluation | 27.3 | 0 | 2 |
| Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet | 27.3 | 0 | 2 |
| Expectations for success in fertility treatment involving assisted reproduction | 27.3 | 0 | 2 |
| Reproductive medicine in transition: new developments in embryo transfer | 27.3 | 0 | 2 |
| Intrauterine insemination or intracervical insemination with cryopreserved donor sperm in the natural cycle: a cohort study | 27.3 | 0 | 2 |
| Results of donor insemination related to specific male infertility and unsuspected female infertility | 27.3 | 0 | 2 |
| Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship programs. | 27.3 | 0 | 2 |
| Annual report of Reproductive Endocrinology Committee, Japan Society of Obstetrics and Gynecology, 2013 | 27.3 | 0 | 2 |
| Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells (PBMC) promotes live birth rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure | 27.3 | 0 | 2 |
| The use of urine LH detection kits to time intrauterine insemination with donor sperm | 27.3 | 0 | 2 |
| Evaluation of the relation between preapoptotic sperm rate in ejaculate and intrauterine insemination success rate in patients with unexplained infertility | 27.3 | 0 | 2 |
| Luteal phase support after mild ovulation induction with intrauterine insemination: an on-going debate | 27.3 | 0 | 2 |
| Reversible cerebral vasoconstriction syndrome associated with hormone therapy for intrauterine insemination | 27.3 | 0 | 2 |
| Revised guidelines for human embryology and andrology laboratories | 27.3 | 0 | 2 |
| A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor. | 27.3 | 0 | 2 |
| Vaccination guidelines for female infertility patients | 27.3 | 0 | 2 |
| Association of the number of follicles of various sizes and treatment protocol with multiple pregnancies following ovulation induction and intrauterine insemination | 27.3 | 0 | 2 |
| Semen analysis and successful paternity by intracytoplasmic sperm injection in a man with steroid 5α-reductase-2 deficiency | 27.3 | 0 | 2 |
| Vaccination guidelines for female infertility patients | 27.3 | 0 | 2 |
| High basal LH levels in combination with low basal FSH levels are associated with high success rates at assisted reproduction | 27.3 | 0 | 2 |
| Effectiveness of intrauterine insemination in subfertile couples with an isolated cervical factor: a randomized clinical trial | 27.3 | 0 | 2 |
| Varicocelectomy improves intrauterine insemination success rates in men with varicocele | 27.3 | 0 | 2 |
| AIDA for reproductive medicine and the fertility clinic | 27.3 | 0 | 2 |
| Subnormal sperm parameters in conventional semen analysis are associated with discrepancies between fertilization and pregnancy rates in in-vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| Factors influencing the success rate of human embryo freezing in an in vitro fertilization and embryo transfer program. | 27.3 | 0 | 2 |
| Methods for detecting occupational causes of male infertility. Reproductive history versus semen analysis. | 27.3 | 0 | 2 |
| Clinical analysis of 50 patients with heterotopic pregnancy after ovulation induction or embryo transfer | 27.3 | 0 | 2 |
| The effect of intrauterine human chorionic gonadotropin flushing on live birth rate after vitrified-warmed embryo transfer in programmed cycles: a randomized clinical trial | 27.3 | 0 | 2 |
| Gestational carrier use in assisted reproductive technology: what can it tell us about the uterine role in infertility? | 27.3 | 0 | 2 |
| Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study | 27.3 | 0 | 2 |
| Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? | 27.3 | 0 | 2 |
| Development of a high-resolution Y-chromosome microarray for improved male infertility diagnosis | 27.3 | 0 | 2 |
| Safety of the offspring conceived by assisted reproductive technology with cryopreserved donor sperm | 27.3 | 0 | 2 |
| The views of adult offspring of sperm donation: essential feedback for the development of ethical guidelines within the practice of assisted reproductive technology in the United States | 27.3 | 0 | 2 |
| Economic implications of the Society for Assisted Reproductive Technology embryo transfer guidelines: healthcare dollars saved by reducing iatrogenic triplets | 27.3 | 0 | 2 |
| The relationship of sperm DNA fragmentation index with the outcomes ofin-vitrofertilisation-embryo transfer and intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Estrous cycle staging before mating led to increased efficiency in the production of pseudopregnant recipients without negatively affecting embryo transfer in mice | 27.3 | 0 | 2 |
| Pregnancy after endometrial scratching in infertile couples undergoing ovulation induction and intrauterine insemination cycles-a randomized controlled trial | 27.3 | 0 | 2 |
| Anti-Müllerian hormone levels after laparoscopic cystectomy for endometriomas as a possible predictor for pregnancy in infertility treatments | 27.3 | 0 | 2 |
| AIUM practice guideline for ultrasonography in reproductive medicine | 27.3 | 0 | 2 |
| 'Elective single embryo transfer (eSET) reduces pregnancy rates and should only be used in exceptional circumstances': AGAINST: SET maintains live birth rates and provides unique advantages | 27.3 | 0 | 2 |
| Clinical effects of oocyte cryopreservation in assisted reproduction technology | 27.3 | 0 | 2 |
| Male infertility with severe oligospermatism and azoospermia treated by Bushen Shengjing Decoction combined with intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| How to improve ART results? Is France behind other countries? Strategy for single embryo transfer: The value of embryo selection and embryo freezing | 27.3 | 0 | 2 |
| Surveillance of congenital malformations in infants conceived through assisted reproductive technology or other fertility treatments | 27.3 | 0 | 2 |
| Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study | 27.3 | 0 | 2 |
| Distributive justice and the regulation of fertility centers: an analysis of the Fertility Clinic Success Rate and Certification Act. | 27.3 | 0 | 2 |
| Significant medical pathology uncovered by a comprehensive male infertility evaluation. | 27.3 | 0 | 2 |
| Cryopreservation of the occasionally improved semen samples for intrauterine insemination: a new approach in the treatment of idiopathic male infertility | 27.3 | 0 | 2 |
| Ovulation induction with gonadotropins as sole treatment in infertile couples with open tubes: a randomized prospective comparison between intrauterine insemination and timed vaginal intercourse | 27.3 | 0 | 2 |
| Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients | 27.3 | 0 | 2 |
| Maternal serum β-hCG levels in screening for Down syndrome are higher in singleton pregnancies achieved with ovulation induction and intrauterine insemination than in spontaneous singleton pregnancies | 27.3 | 0 | 2 |
| Factors affecting live birth rate in intrauterine insemination cycles with recombinant gonadotrophin stimulation. | 27.3 | 0 | 2 |
| Recommendations for practices utilizing gestational carriers: a committee opinion | 27.3 | 0 | 2 |
| Re: Effect of Semen Quality on Human Sex Ratio in In Vitro Fertilization and Intracytoplasmic Sperm Injection: An Analysis of 27,158 Singleton Infants Born after Fresh Single-Embryo Transfer | 27.3 | 0 | 2 |
| Reproductive endocrinology: Hormone therapy to treat menopause--breaking a taboo | 27.3 | 0 | 2 |
| In-vitro fertilization, embryo transfer, and embryo freezing | 27.3 | 0 | 2 |
| Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles. | 27.3 | 0 | 2 |
| Effect of oocyte transportation time on the clinical results of transport in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 27.3 | 0 | 2 |
| Testicular sperm extraction with intracytoplasmic sperm injection for male infertility | 27.3 | 0 | 2 |
| Systematic review of antioxidant types and doses in male infertility: Benefits on semen parameters, advanced sperm function, assisted reproduction and live-birth rate | 27.3 | 0 | 2 |
| Trust women to choose: a response to John a Robertson's 'Egg freezing and Egg banking: empowerment and alienation in assisted reproduction'. | 27.3 | 0 | 2 |
| Unravelling orders in a borderless Europe? Cross-border reproductive care and the paradoxes of assisted reproductive technology policy in Germany and Poland | 27.3 | 0 | 2 |
| Severe ovarian hyperstimulation syndrome in a 42-year-old woman with successful pregnancy after intracytoplasmic sperm injection embryo transfer | 27.3 | 0 | 2 |
| Prediction of male infertility by the World Health Organization laboratory manual for assessment of semen analysis: A systematic review. | 27.3 | 0 | 2 |
| Male infertility, azoozpermia and cryptozoospermia incidence among three infertility clinics in Turkey | 27.3 | 0 | 2 |
| Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process | 27.3 | 0 | 2 |
| Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE† | 27.3 | 0 | 2 |
| Preimplantation diagnosis after assisted reproduction techniques for genetically-determined male infertility | 27.3 | 0 | 2 |
| The challenges of supporting male infertility treatment in South Africa | 27.3 | 0 | 2 |
| Pregnancy and Neonatal Outcomes in Azoospermic Men After Intracytoplasmic Sperm Injection Using Testicular Sperm and Donor Sperm | 27.3 | 0 | 2 |
| Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women | 27.3 | 0 | 2 |
| Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors | 27.3 | 0 | 2 |
| Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion | 27.3 | 0 | 2 |
| An assessment of current clinical attitudes toward letrozole use in reproductive endocrinology practices | 27.3 | 0 | 2 |
| In-vitro fertilization (IVF), embryo transfer (ET) and assisted reproduction in the State of Israel | 27.3 | 0 | 2 |
| Characteristics and Outcomes of Female Infertility Treatment Programs Using Traditional Medicine in Korea: A Multisite Analysis | 27.3 | 0 | 2 |
| The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling | 27.3 | 0 | 2 |
| Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function | 27.3 | 0 | 2 |
| Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer | 27.3 | 0 | 2 |
| Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence? | 27.3 | 0 | 2 |
| Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference | 27.3 | 0 | 2 |
| Position statement on West Nile virus: a committee opinion | 27.3 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage | 27.3 | 0 | 2 |
| Egg donation model: an excellent way to isolate and analyze the impact of the male partner on assisted reproductive technology outcome | 27.3 | 0 | 2 |
| Current recommendations for vaccines for female infertility patients: a committee opinion | 27.3 | 0 | 2 |
| Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management - meta-analyses | 27.3 | 0 | 2 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 27.3 | 0 | 2 |
| Silver-Rusell syndrome caused by epigenetic alteration in a child conceived by intrauterine insemination from donor sperm | 27.3 | 0 | 2 |
| Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective? | 27.3 | 0 | 2 |
| Menopausal hormone therapy—ovarian cancer risk revisited | 27.3 | 0 | 2 |
| Meta-analysis of the association between chromosomal polymorphisms and outcomes of embryo transfer following in vitro fertilization and/or intracytoplasmic sperm injection | 27.3 | 0 | 2 |
| Sharing of human leukocyte antigens in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer | 27.3 | 0 | 2 |
| Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Consideration of the gestational carrier: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Misconduct in third-party assisted reproduction: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Re: Fertility Preservation for Men with Testicular Cancer: Is Sperm Cryopreservation Cost Effective in the Era of Assisted Reproductive Technology? | 27.3 | 0 | 2 |
| Ovulation induction and intrauterine insemination in infertile women with polycystic ovary syndrome: A comparison of drugs | 27.3 | 0 | 2 |
| Micromanipulation of Human Oocytes and Embryos: Applications of Intracytoplasmic Sperm Injection and Assisted Hatching in Infertility Treatment | 27.3 | 0 | 2 |
| Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinion | 27.3 | 0 | 2 |
| Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Informing offspring of their conception by gamete or embryo donation: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Gender reassignment and assisted reproduction: An ethical analysis. Bristol Centre for Reproductive Medicine Ethics Advisory Committee | 27.3 | 0 | 2 |
| Shared-risk or refund programs in assisted reproduction. The Ethics Committee of the American Society for Reproductive Medicine | 27.3 | 0 | 2 |
| The use of assisted reproductive technology before male factor infertility evaluation | 27.3 | 0 | 2 |
| Success rates and cost of a live birth following fresh assisted reproduction treatment in women aged 45 years and older, Australia 2002-2004 | 27.3 | 0 | 2 |
| The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow-up study**Presented in part at the 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Wa | 27.3 | 0 | 2 |
| Mid-Luteal 17-OH Progesterone Levels in 614 Women Undergoing IVF-Treatment and Fresh Embryo Transfer—Daytime Variation and Impact on Live Birth Rates | 27.3 | 0 | 2 |
| Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction | 27.3 | 0 | 2 |
| Unexplained Infertility and the Possibilities of Management with In Vitro Fertilization and Embyro Transfer | 27.3 | 0 | 2 |
| The relationship of tubal blockage, infertility of unknown cause, suspected male infertility, and endometriosis to success of in vitro fertilization and embryo transfer | 27.3 | 0 | 2 |
| 27. Folate and female infertility: folate-metabolizing pathway in folliculogenesis, infertility treatment, and implantation | 27.3 | 0 | 2 |
| Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents | 27.3 | 0 | 2 |
| Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial | 27.3 | 0 | 2 |
| Does surgery improve live birth rates in patients with recurrent miscarriage caused by uterine anomalies? | 27.3 | 0 | 2 |
| Large for gestational age and macrosomia in singletons born after frozen/thawed embryo transfer (FET) in assisted reproductive technology (ART) | 27.3 | 0 | 2 |
| La cryopréservation ovocytaire va-t-elle relancer l’intérêt du prélèvement chirurgical de spermatozoïdes synchrone du recueil ovocytaire en cas d’azoospermie non obstructive ? | 27.3 | 0 | 2 |
| Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved | 27.3 | 0 | 2 |
| Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer | 27.3 | 0 | 2 |
| Predictive Factors of Ovarian Response in Ovulation Induction With Intrauterine Insemination of a Gonal-f Low-dose Regimen | 27.3 | 0 | 2 |
| Single Human Embryo Transfer in Assisted Reproduction Programs | 27.3 | 0 | 2 |
| Prevalence of abnormal semen analysis and levels of adherence with fertility preservation in men undergoing therapy for newly diagnosed cancer: A retrospective study in 2906 patients | 27.3 | 0 | 2 |
| Health in Childhood Following Assisted Reproductive Technology | 27.3 | 0 | 2 |
| Follicular response and pregnancy among infertile women undergoing ovulation induction and intrauterine insemination | 27.3 | 0 | 2 |
| GnRH Agonist at Embryo Transfer: IVF Outcomes | 27.3 | 0 | 2 |
| Clinical Cohort Study on the Endocrinology and Vaginal Microbiome of the Luteal Phase in Assisted Reproduction | 27.3 | 0 | 2 |
| Effect of Intrauterine Injection of Hcg Before ET on Clinical Outcomes in IVF/ICSI Cycles | 27.3 | 0 | 2 |
| The Effect of Embryo Culture Under Low Oxygen Tension on Pregnancy Rates | 27.3 | 0 | 2 |
| Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART) | 27.3 | 0 | 2 |
| Oocyte Cryopreservation | 27.3 | 0 | 2 |
| Extended Letrozole Regimen Versus Clomiphene Citrate for Superovulation in Patients With Unexplained Infertility Undergoing Intrauterine Insemination | 27.3 | 0 | 2 |
| Preimplantation genetic screening (PGS): a tool to increase live birth rates in couples with unexplained recurrent miscarriage? | 27.3 | 0 | 2 |
| The Value of Prednisolone With Aspirin Before Embryo Transfer in Intracytoplasmic Sperm Injection (ICSI) Cycles | 27.3 | 0 | 2 |
| Effects of Clomiphene Citrate Ovulation Induction on Frozen Embryo Transfer | 27.3 | 0 | 2 |
| Effect of Oxytocin Antagonists on Implantation Success Rates of Frozen-thawed Embryo Transfer | 27.3 | 0 | 2 |
| Does the Embryo Transfer Technique Affect the Success of in Vitro Fertilization? | 27.3 | 0 | 2 |
| Comparing HEPES-buffered With Bicarbonate-buffered as Handling Media During the ICSI Procedure on Live Birth Rate | 27.3 | 0 | 2 |
| EXpression PRofile Endometrium Samples Study | 27.3 | 0 | 2 |
| Does Local Injury of the Endometrium Improve Controlled Ovarian Hyperstimulation (COH) + Intrauterine Insemination (IUI) Outcome? | 27.3 | 0 | 2 |
| Endometrial Injury for Assisted Reproduction | 27.3 | 0 | 2 |
| Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity | 27.3 | 0 | 2 |
| Frontiers in hormone therapy for male infertility | 27.3 | 0 | 2 |